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Purpose: Post-concussion syndrome (PCS) is a complex neurological disorder in which various 
concussion symptoms can last for weeks, months, or even years after sustaining the 
concussion. The PCS population has been shown to have some functional deficits such as 
balance and visual-motor integration issues in addition to their PCS symptoms. The current 
study has three main objectives as follows: 1) to establish a comprehensive visual function test 
battery for use in both control and PCS individuals, 2) to compare performance on the 
comprehensive visual function test battery in control and PCS individuals, 3) to determine if 
performance on the comprehensive visual function test battery is in any way related to the 
symptoms individuals with PCS experience. 
Methods: Forty-four participants aged 18 - 35 were recruited. The study participant groups 
were as follows: 1) Healthy participants with no history of concussion (Controls; n=33), and 2) 
Participants with PCS (n=11). Participants completed two study visits separated by 2 - 7 days. 
The testing protocol of visit 1 consisted of the following visual function tests: static visual 
perception, objective refraction, ocular alignment, ocular motility, stereopsis, accommodative 
function, vergence function, cyclopean eye alignment position, and King-Devick. The testing 
protocol of visit 2 consisted of visual-motor integration tests including visual-motor reaction time 
and coincidence anticipation timing, and a test of dynamic visual perception. 
Results: All control and PCS participants were able to complete all of the tests at each study 
visit. However, the PCS participants took longer time to complete the study visits as these 
participants needed breaks to rest between some of the tests. Control participants did not need 
breaks between any of the tests. A Mann-Whitney U-test was conducted to examine the 
difference in visual function performance between the groups. Overall, the only difference 
shown between the two groups was in the ocular motility, King-Devick, cyclopean eye alignment 
position, and the peripheral visual-motor reaction time tests. In the ocular motility test, 30% of 
PCS participants exhibited irregular eye movements, whereas 0% of control participants had 
irregular eye movements. On the King-Devick test, the control group appeared to read faster 
than the PCS group (p=0.04). On the cyclopean eye alignment position test, which is a measure 
of global visual function, the PCS group appear to have better performance and made fewer 
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errors in alignment (p=0.03). On the peripheral visual-motor reaction time test, the PCS group 
also appeared to have better peripheral reaction time than the control group (p=0.04). 
To examine the relationship between PCS symptom severity and visual function, a Spearman 
correlation analysis was conducted. For the control group, stereopsis (p=0.02), distance 
horizontal negative fusional reserve - blur point (p=0.04), distance vertical negative fusional 
reserve - double point (p=0.01), and recovery point (p=0.02) were found to be significantly 
correlated with participant symptoms. For the PCS group, there was a statistically significant 
correlation for a few coincidence anticipation error measures. The vast majority of the 
correlations between symptom severity and visual function were not significant in either group, 
which suggests that performance on the visual function test battery is not predictive of 
participant symptoms.   
Conclusion: In summary, this study has applied a comprehensive visual function testing 
protocol that can be used in further research and clinical practice. Eye movement tests such as 
the Broad H oculomotor screening test, and the King-Devick test appear to have the potential to 
detect lingering deficits in the PCS population. Additionally, PCS related symptoms do not 
appear to be related to performance on the individual visual function tests used in the test 
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 - Introduction 
1.1 Concussion definition 
Concussion is a complex pathophysiological process which impacts brain function, resulting 
from a biomechanical force that is directed to the head, face, neck or transmitted to the head 
from elsewhere in the body.1 Concussion is considered to be a subset of mild traumatic brain 
injury (mTBI) although the two terms have been used interchangeably in the literature.1,2 
1.2 Concussion pathology 
Concussion is known as a short-lasting disturbance of the brain function induced by 
acceleration and/or deceleration of the head.3 This neurological disturbance is thought to be due 
to a neurometabolic disruption rather than an obvious structural change such as swelling or 
bleeding of the brain. Because there are no obvious structural changes associated with 
concussion, concussion is typically associated with normal findings on conventional 
neuroimaging techniques such as computed tomography (CT) or magnetic resonance imaging 
(MRI).1,3 These normal conventional neuroimaging findings distinguish concussion from other 
types of TBI that cause structural changes in the brain.1,3 
In an acutely concussed individual, neuronal cell metabolism is altered. The affected neurons 
release potassium (K+) and absorb toxic calcium ions (Ca2+), which causes increased glucose 
uptake by the cells in an attempt to regulate the cell metabolic state. The resulting altered cell 
metabolic state results in the release of free radicals that impact the cell’s DNA and the cell 
membrane. About 30 minutes after the concussion, the brain will begin to experience low levels 
of glucose uptake and cerebral blood flow, and the cell’s mitochondria absorb the excess Ca2+ 
in the cell.  The absorption of Ca2+ by cell mitochondria has a negative impact on mitochondrial 
function and results in an energy crisis. This metabolic imbalance affects all of the cells, even 
those that survived the initial insult and is thought to be the cause of the myriad of symptoms 
that individuals with concussion experience.3,4 
Controversially, some research suggests that the altered neural metabolism caused by an acute 
concussion actually results in structural changes in the brain and leads to axonal swelling and 
damage, which consequently affects the neural connections. While this structural damage is not 
detected by conventional neuroimaging, it appears to be detectable by a technique called 
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magnetic resonance diffuse tensor imaging (DTI). This technique showed a potential in 
detecting microstructural changes in the integrity of the brain white matter after concussion.5 
Unfortunately, DTI is an expensive neuroimaging technique so there has not been widespread 
uptake and acceptance of this imaging technique yet in research and clinical practice.5,6  
1.3 Concussion by the numbers 
In Canada, concussion is the seventh most serious injury among individuals aged 12 and over.7 
110 Canadians per 100,000 reported concussion as their most serious injury.8 Of all reported 
concussions, 54% are sports-related and occur at sports or recreation places.8 Concussions not 
related to sport have been found to occur at a number of places including the home (26%), 
school (7%), and streets/highways (4%).8  
Concussion incidence rates have been found to be higher in males (140 per 100,000) than 
females (80 per 100,000).8 Moreover, concussions are more common in younger adults (16 - 34 
years old) than other age groups.8 In athletes specifically, results from The National Collegiate 
Athletic Association (NCAA) has found concussion incidence rates are higher among collegiate 
athletes than high school athletes.9 
1.4 Concussion in sport 
Despite the fact that there are many causes of concussion, most of the literature on concussion 
focuses primarily on sports-related concussion. The preponderance of sports-related 
concussion literature could be because of the need for sports to have safe and clear regulations 
to keep athletes safe and healthy in the game.1,10 It may also be due to the fact that sports are 
high-risk environments for concussions and that athletes are a relatively homogenous 
population to study, or that sports-related concussions seem to be associated with fewer co-
morbidities at the time of injury (compared to motor vehicle accidents for example). Concussion 
research in sport has a long history and has paved the way for further research in many areas 
of concussion research. Despite differences in populations and injury mechanisms between 
sports-related and non-sports-related concussions, the most recent consensus statement of the 
International Conference on Concussion in Sport stated that there are no validated criteria to 
distinguish sport-related concussion from other types of head injuries10, and that research 
findings on sport-related and non-sport-related concussion should be considered complimentary 
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to each other.10 Therefore, the references used in this thesis are not limited solely to sport-
related concussion research. 
1.5 Concussion diagnosis 
Previous research studies investigating biochemical markers, neuroimaging, and 
electrophysiological tests to diagnose concussion objectively have had unsatisfactory 
outcomes.1,10 Therefore, clinicians diagnose concussion based on the patient’s reported history 
which must include a mechanism of injury, presenting signs and/or symptoms, and 
neuroimaging tests to confirm that obvious structural abnormalities are absent and exclude 
more severe types of TBI.1 The domains assessed in the diagnosis of concussion include 
screening for 1) somatic, cognitive, emotional, or sleep disturbance symptoms, 2) balance 
deficits, 3) behavioural changes, and 4) cognitive deficits such as slow reaction times.1,3,10 
It is important to note that individuals do not need to lose consciousness to have a concussion, 
nor do they need to experience all of the symptoms / signs listed above.1,3,10 
1.6 Concussion recovery 
Clinical concussion recovery is determined by returning to normal daily life activities,10 and 
involves the resolution of symptoms and the return of normal physiological functions such as 
balance.10 Research has determined that the majority of concussed individuals recover within 
two weeks after sustaining their injury.10 However, the concussion recovery period is still a 
vague and subjective phenomenon because of the lack of objective methods to monitor 
recovery.1,3 In other words, it is still unclear when it is safe to permit a concussed individual to 
return to daily life activities including work, school, sport, etc. Defining a specific concussion 
recovery time frame is complicated by the fact that some concussed individuals experience 
symptoms and other physiological deficits that last beyond the typical two week healing 
period.1,3 When concussion recovery is prolonged, it is described as Post-Concussion 
Syndrome, which is discussed in more detail below.5 
1.7 Post-Concussion Syndrome (PCS) 
Post-concussion syndrome (PCS) is a complex neurological disorder in which various 
concussion symptoms such as headache, dizziness, and loss of concentration last for weeks, 
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months, or even years after sustaining the concussion.3,11 The prevalence of post-concussion 
syndrome varies amongst the literature. This variation may be attributed to the difference 
between the population samples of each study in terms of age, gender, and population size, or it 
may be attributed to differences in the definition of PCS, which are discussed in more detail 
below. Generally, somewhere between 10 to 64% of concussed individuals will develop post-
concussion syndrome.12–15 Interestingly, the percentage of individuals who suffer from PCS 
appears to increase when studying only a single symptom such as headache, which has been 
shown to persist in up to 90%16 of individuals following a concussion. 
While population differences likely contribute to some of the variability in the literature about 
PCS, a more notable reason that the prevalence of PCS is so variable is that there is 
uncertainty in literature around defining what PCS actually is. Part of this uncertainty is due to 
the different schools of thought about the underlying causes of PCS.3 Some specialists believe 
that PCS is directly related to the sustained concussion, while others believe that PCS reflects 
the psychological and emotional status of the concussed individual.3,17 
Another reason for the uncertainty around defining PCS is that the two main and widely 
acceptable diagnostic systems; the Diagnostic and Statistical Manual of Mental Diseases, 4th 
edition (DSM-IV)3 and the World Health Organization’s International Classification of Diseases, 
10th edition (ICD-10),3,18 have different definitions of and diagnostic criteria for PCS.3  
The DSM-IV defines PCS as: 1) cognitive deficits in attention or memory and 2) at least three or 
more of the following concussion symptoms: fatigue, sleep disturbance, headache, dizziness, 
irritability, affective disturbance, apathy, or personality change, that persist for at least 3 months 
after the injury.3 On the other hand, the ICD-10 defines PCS as the presence of three of the 
following concussion symptoms: headache, dizziness, fatigue, irritability, insomnia, 
concentration or memory difficulty without marked neurological impairment or reduced alcohol 
intolerance, that persist for at least 4 weeks after the concussion incident.18 
In 2005, a study was conducted to determine the effectiveness of the two diagnostic systems.19 
178 TBI patients were interviewed and evaluated using the DSM-IV and the ICD-10 systems.19 
11% of the participants were diagnosed with PCS using the DSM-IV system compared to 64% 
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using the ICD-10.19 This result demonstrates that the ICD-10 definition of PCS is more liberal 
and results in a higher number of PCS diagnoses.19 Although studies such as this one have 
started to explain some of the variability in the incidence of PCS, the question about what the 
underlying cause of PCS remains unanswered. 
Perhaps the greatest challenge in defining PCS lies in the fact that it is a condition based on 
symptoms alone. It is been argued that relying on symptoms alone to diagnose PCS is 
inadequate because these symptoms are prevalent in the general population as well.20,21 In 
2011, a study was conducted to compare the prevalence of PCS symptoms between a 
previously concussed group and a control group with no history of concussion. Interestingly, the 
prevalence of PCS symptoms in the control group was higher (34%) than the previously 
concussed group (30%).14 Thus, it has been recommended that the PCS population should be 
examined using multidisciplinary approaches in order to determine objective methods to define 
and diagnose PCS, improve recovery monitoring, and develop intervention treatment plans.1,14,21 
One of the earliest research studies that contributed to a better understanding of the functional 
recovery post-concussion was done in 2006. The study was conducted to assess visuomotor 
function in combination with balance function of concussed individuals at baseline (prior to 
concussion), and at 3, 10 and 30 days post-injury. A total of 55 participants were included in this 
study; 10 of these participants had a concussion after the baseline test. The test used consisted 
of a virtual reality moving room stimulus. The natural response to this type of stimulus is to sway 
in the same direction of the movement as the presented stimulus. The authors used a 
coherence analysis to determine whether participant’s movement was at the same frequency 
and direction as the moving room. Participants performed as expected on the task at baseline.  
Interestingly, concussed participants were not able to perform the task at all on day 3 post-
concussion, which was attributed to deficits in participant’s visuomotor integration abilities that 
were attributed to the concussion incident. At day 10, the concussed participants still did not 
perform the task properly and displayed an abnormal sway movement in response to the 
presented stimulus that was significantly different compared to baseline. At day 30, no 
significant difference between the baseline and the day 30 results, therefore, the authors 
concluded that visuomotor recovery had occurred at one month after sustaining the concussion. 
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Based on the study described above, a number of research studies have examined PCS using 
the ICD-10 diagnostic criteria of 3 or more concussion related symptoms that persist for 30 days 
after the injury.22–24 Interestingly, the studies conducted with this definition of PCS found that 
visuomotor, vestibulo-ocular, and / or balance deficits were actually present in PCS individuals 
one month after their injury.22–24 
1.8 Visual function in concussion and PCS 
Many of the aforementioned deficits in PCS rely heavily on vision as a main input. It has also 
been determined that visual pathways incorporate more than half of the brain circuits.25 Thus, 
studying a wide array of different visual functions such as accommodation, eye movements, and 
stereopsis might contribute to a better understanding of the vision-related deficits in both PCS 
and concussion. Understanding how visual functions and their underlying neurological pathways 
are affected by concussion and PCS will help to inform how brain function is affected in PCS 
and concussion, especially if a comprehensive visual function battery is applied. 
Visual dysfunctions have been reported in individuals with TBI since the 80’s.26–33 It is important 
to recognize that although the studies that have been done highlight the wide array of visual 
dysfunctions associated with TBI, these studies still have some limitations that need to be 
addressed with further research.  
First of all, some of the earliest studies looked at the visual dysfunctions of individuals with all 
types of TBI, irrespective of the severity of the injury.26,27,29,30 This limitation was addressed in 
later studies, especially when it was understood that moderate and severe TBI were associated 
with visual impairments such as visual field loss, whereas mild TBI and concussion where 
associated more with visual dysfunctions such as accommodation disorders.27–31,33 
Unfortunately, some of the later studies that examined specific TBI severities were conducted 
without a control group. Furthermore, several examiners often completed the visual function 
tests in these studies, which makes it hard to draw firm conclusions from their results because 
of the increased risk of inter-examiner difference bias. Additionally, the time since the initial 
concussion injury was not always specified, which makes it hard to understand if the reported 




Some of the most recent research studies have focused on investigating the visual dysfunctions 
associated with concussion in the acute phase - prior to 30 days post injury.34,35 However, these 
studies did not follow their participants out past this time point; therefore, it is still unclear if 
these visual dysfunctions persisted beyond the 30-day time period when the PCS occurred. It is 
also unclear if, or how often, visual functions recovered within the 30-day period. Moreover, the 
relationship between the PCS symptoms and the potential associated visual dysfunctions has 
not been fully studied. 
Examining visual functions in PCS and accounting for the time since injury could contribute to a 
better understanding of the condition. Also, examining a broader range of visual functions in 
PCS could help explain the presence of other deficits that rely on vision such as vestibular and 
balance deficits. If the vision dysfunctions due to PCS help explain some of the other deficits 
associated with PCS then vision tests could be implemented in conjunction with other 
behavioural tests to provide better care to the PCS population.  
In addition to the population and time since injury challenges identified above, there are some 
more specific challenges that researchers need to be aware of when they conduct vision 
research in the PCS population. These challenges are as follows:  
1) There is a lack for objective and validated tests that examine specific functions such as 
light sensitivity which is one of the vision related symptoms associated with PCS.36  
2) The current eye exam protocols consist of traditional visual function tests such as 
visual acuity, contrast sensitivity, and binocular vision tests; however, these protocols 
do not include novel and newly established tests such as dynamic visual acuity and 
visual-motor reaction time, which provide additional insight about the integrity of the 
brain function, but are not normally conducted in a routine eye exam. 
3) As many tests such as dynamic visual acuity and visual-motor reaction time have not 
been studied in individuals with PCS, it is unknown how these tests will relate to the 
more traditional test battery, or if these tests can be done in the PCS population 
without provoking symptoms. Therefore, there is a need to develop test battery for the 




4) Considering that PCS individuals experience a myriad of symptoms, they seek 
treatments from different clinicians such as general practitioners and physiotherapists. 
These treatments, whether they are medications (i.e. antidepressants) or therapy 
protocols (i.e. vision training) could have an effect on visual functions.37,38 Thus, it 
would be better if these treatments were controlled or at least accounted for as variable 
in study designs. 
The current study will address some of these challenges as discussed in the study objectives. 
1.9 Overall objective 
The overall objective of this study is to determine if the visual dysfunctions associated with PCS 
can be measured using a comprehensive visual function test battery. Additionally, this study will 
determine if the visual dysfunctions associated with PCS are related to persistent post-injury 
symptoms. Ultimately this study will help to inform whether or not the visual dysfunctions 
associated with PCS have the potential to be used as objective markers of PCS recovery. 
1.9.1 Research objectives 
1) To apply a comprehensive visual function test battery in both control and PCS 
individuals. 
2) To compare performance on the comprehensive visual function test battery in control 
and PCS individuals. 
3) To determine if performance on the comprehensive visual function test battery is in any 
way related to the symptoms that individuals with PCS experience.  
1.9.2 Research hypotheses 
1) The applied visual function testing protocol will be feasible (i.e. all tests will be able to 
be completed in all participants) in both the control and the PCS groups. 
2) The PCS group will possess marked visual dysfunctions compared to the control 
group. 




 - Methods 
2.1 Study design 
This observational/exploratory cohort study was primarily designed to determine the difference 
between PCS and control groups using a comprehensive visual function test battery. This study 
received ethics clearance from the Office of Research Ethics at the University of Waterloo 
(ORE# 20279). 
2.2 Study participants 
Forty-four participants between 18 - 35 year of age were recruited. The study participant groups 
are as follows: 1) Healthy participants with no history of concussion (Controls; n=33), and 2) 
Participants with PCS (n=11). One PCS participant was excluded from data analysis for not 
meeting the inclusion criteria, therefore (n=10) participants were included in the PCS group for 
analysis purposes. Participants were recruited from the University of Waterloo (UW), Wilfrid 
Laurier University (WLU), UW Varsity Athletics, WLU Varsity Athletics, and the Kitchener-
Waterloo residential community. 
2.2.1 Inclusion / Exclusion criteria of the control group 
2.2.1.1 Inclusion 
1) 18 - 35 years old 
2) Consent of participation  
2.2.1.2 Exclusion 
1) A history of concussion 
2) Any self-reported history of an eye problem that had an impact on the participant’s vision 
such as glaucoma 





2.2.2 Inclusion / Exclusion criteria of the PCS group 
2.2.2.1 Inclusion 
1) 18 - 35 years old 
2) Consent of participation 
3) A history of concussion 
4) A minimum of three persisted concussion symptoms 30 days after the most recent 
concussion 
The examiner will attempt to recruit individuals in both the control and PCS groups who have 
similar sport backgrounds and/or physical activity levels if possible.  
2.2.2.2 Exclusion 
1) Any self-reported history of an eye problem that had an impact on the participant’s vision 
such as glaucoma 
2) Presence of a manifest binocular vision disorder (i.e. amblyopia, nystagmus, strabismus) 
that occurred before the most recent sustained concussion 
2.3 Study protocol 
Participants successfully completed two study visits separated by 2 - 7 days. Standardizing the 
days between the study visits was particularly important for the PCS group because the time 
between visits needed to be long enough for participants to recuperate from any symptom 
provocation that occurred during the study visit, without being so long that substantial injury 
recovery could occur. The length of the study visits was about 1 hour and 20 minutes for visit 1 
and 45 to 60 minutes (1 hour) for visit 2. The tests performed as part of the comprehensive 
visual function test battery are listed below in (Table 2-1). More detail on how the tests were 
specifically conducted is available in Section 2.4, Visual function tests. 
The comprehensive visual function test battery was designed based on an in-depth review of 
the literature. The test battery included assessments of all of the most commonly reported TBI-
associated visual dysfunctions (e.g. accommodation tests), as well as a few additional novel 
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tests (such as dynamic visual acuity), which were thought to have potential for quantifying visual 
dysfunctions in the PCS population.  
Table 2-1: Visual function tests conducted in each visit; tests are listed in the order they were 
completed for all participants 
Visit 1 Visit 2 
Visual Function Tests 
• King-Devick test 
• Static distance visual acuity test 
• Static near visual acuity test 
• Distance ocular alignment tests 
• Near ocular alignment tests 
• Contrast sensitivity test 
• Ocular motility test 
• Stereopsis test 
• Accommodation accuracy test 
• Cyclopean eye alignment position test 
• Amplitude of accommodation test 
• Near point of convergence test 
• Distance fusional reserve tests 
• Near fusional reserve tests 
• Negative and positive relative 
accommodation tests 
• Accommodative facility test 
• Vergence facility test 
• Objective refraction test 
Visual Function Tests 
• Dynamic visual acuity tests 
• Visual-motor reaction time tests 
• Coincidence anticipation timing tests 
 
Additional tests (not included in the thesis): 





2.3.1 Study health history questionnaires 
In the first study visit, all participants had to complete two health history questionnaires. The first 
health history questionnaire included questions about sports activities, history of concussions, 
and current symptoms. Control participants were asked to skip concussion related questions. 
The second questionnaire was an ocular health history questionnaire that included questions 
about eye diseases, family ocular health history, and vision training. Moreover, PCS participants 
had to complete an additional third questionnaire to gather more information specifically about 
their concussion injuries. A copy of all three questionnaires can be found in Appendix A. 
In the second visit, participants were asked to repeat the current symptoms section of the first 
health questionnaire. This was done in order to look at the relationship between the reported 
symptoms and the visual function in each visit. 
2.4 Visual function tests 
All tests were performed under full room illumination (400 lux) unless indicated otherwise. Also, 
all tests were performed with participants’ habitual vision. In other words, participants were 
asked to wear their current refractive correction (if they had one). For all monocular tests, right 
eye (OD) and left eye (OS) were tested, respectively. If a binocular test was performed, then 
both eyes (OU) were tested after the OS. All tests were done while the participant was 
comfortably seated except for coincidence anticipation timing and visual-motor reaction time, 
which were done with the participant standing. 
2.4.1 Static visual perception 
2.4.1.1 Visual acuity 
Visual acuity (VA) is defined as the ability of the eye to detect fine details.39 It is the most 
commonly used measurement in the assessment of the visual perception. Visual acuity is an 
indicator of the presence of ocular diseases that affect the central retina or its representation in 
the visual pathway and uncorrected refractive errors. Visual acuity can be used to monitor the 




Habitual static visual acuity was measured for all participants at distance (4m) and at near 
(40cm) both monocularly and binocularly.   
2.4.1.1.1 Static distance visual acuity (Visit 1) 
In 1982, Ferris et al. developed the Early Treatment Diabetic Retinopathy Study chart (EDTRS 
chart).40 It is considered as one of the most precise methods to score VA and it is widely used in 
research settings. The EDTRS chart was designed based on the 0.1 logMAR progression of 
letter size suggested by Bailey and Lovie in 1976.41 Each line of the EDTRS chart has a step 
size of 0.1 and five letters. This means each letter has an equal weight of 0.02 logMAR, which is 
the value of the step size divided by the number of letters.40 Thus, per-letter VA scoring of the 
EDTRS chart is precise and effective for clinical research.41 
Static distance visual acuity was measured using a set of EDTRS charts. The charts were 
placed at 4 m from the participant. The luminance on the chart was set to be 320 cd2/m. The 
test was performed monocularly then binocularly, each test being done with a different letter 
chart. Then, VA was calculated with a per-letter scoring system using the following formula:  
VA = the number of the lowest line – (-0.02 X number of wrong answers). 
The mean static distance VA for (20 - 49) years old adult is -0.14 logMAR with a range of -0.02 
to -0.26 logMAR.39,42 
2.4.1.1.2 Static near visual acuity (Visit 1) 
Near visual acuity can be measured with various types of near charts such as continuous near 
text charts.39 Many scientists have suggested that continuous text near charts are effective tools 
for measuring near visual acuity as it relates to everyday tasks because continuous text charts 
mimic, in a controlled way, commonly used reading materials.43,44  
Near visual acuity was measured using the Lighthouse Continuous Text Card - Bee chart at a 
test distance of 40 cm. The card consists of simple sentences designed in lines. The acuity 
ranged from 8.0 to 0.4 M units, which is the text size unit. Monocular and binocular VA tests 
were performed and the results were recorded as the acuity level in M units of the smallest line 
the participant was able to read.  
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2.4.1.2 Contrast sensitivity (Visit 1) 
Contrast sensitivity (CS) is a crucial test for the assessment of visual function. In the real-world, 
we see objects in different contrasts, not just black and white. Thus, the CS test provides useful 
information about real-world vision that is not provided by the VA test. Moreover, the CS test is 
sensitive enough to detect subtle vision changes or losses as is the case in post-refractive 
surgery and multiple sclerosis patients.39,45,46 Therefore, assessment of CS has become 
standard in many clinical research studies. 
CS was measured using the Pelli-Robson letter contrast sensitivity chart at a 1 m test distance 
while participants were comfortably seated. The luminance on the chart was set to be 120cd2/m. 
CS was measured binocularly, and the test score was recorded on the Pelli-Robson recording 
sheet in CS log units. In normal, healthy 20 to 50 years old adults, CS should be 1.80 logCS or 
greater.39,47 
2.4.2 Dynamic visual perception 
2.4.2.1 Dynamic visual acuity (Visit 2) 
In this study, moV& (V&mp Vision Suite, Waterloo, Canada), a specific dynamic visual acuity 
test was performed for all participants. This test was developed and validated in the Vision & 
Motor Performance Lab at the School of Optometry and Vision Science at the University of 
Waterloo, and has been shown to demonstrate good test - retest repeatability.48,49   
DVA was measured binocularly using a Tumbling E target presented on an LED monitor screen 
4 m away from the participant. In this test, three different DVA motion types were used: 1) 
random motion, where the target moved on the screen in a Brownian motion type pattern to 
ensure that the target path was unpredictable, 2) horizontal motion, where the target crossed 
the center of the screen horizontally from left to right, and 3) jitter motion, where the target was 
presented at the centre of the screen and quickly shifted in all directions around the centre.  
The maximum VA, or starting place for the test, was set to be 0.4 logMAR larger than 
participants’ static VA. The letter speed was 1 m/s for the random and horizontal motions, and 
the minimum jitter standard deviation was 1 mm. The target exposure time was a maximum of 
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20 sec. display time for all motion types. Dynamic visual acuity was measured in logMAR using 
a per-letter scoring system. Data were electronically recorded and saved to excel sheets. 
2.4.3 Refractive status 
2.4.3.1 Objective refraction (Visit 1) 
Objective refraction test provides an insight about the eye’s refractive status. The test provides 
a primary measurement of the eye’s refractive error that can be refined later with a subjective 
refraction.39 In this study, an auto-refractor was used to determine the objective refractive 
status. Then, the spherical equivalent was calculated for the OD and OS (right and left eyes, 
respectively) with the following formula: 
Spherical equivalent = spherical power + (0.5*cylindrical power) 
2.4.4 Binocular vision 
2.4.4.1 Ocular alignment (Visit 1) 
The cover test is a routine binocular vision test that determines the presence, type, direction, 
and amount of any ocular misalignment. There are two types of the ocular misalignment: 1) 
Tropia (manifest misalignment) which also called squint, or strabismus, and 2) Phoria (hidden 
misalignemt). In the presence of an ocular misalignment, an eye can deviate inward (eso), 
outward (exo), upward (hyper), or downward (hypo). There are three basic types of the cover 
test as follows: the unilateral cover test which determines the presence of tropia, the alternating 
cover test which determines the presence of phoria in the absence of a positive result on the 
unilateral cover test (i.e. no tropia), and the simultaneous prism cover test which determines the 
amount of the misalignment.39,50 In this study, all of these tests were conducted in: primary, left, 
and right gazes at distance (4m) and near (40cm). 
For distance and near cover tests, the targets used were one line better than the participant’s 
best static VA. Unilateral and alternating cover tests were conducted, respectively. If a deviation 
was found, the simultaneous cover test was done using prism bars. Results were recorded as 




2.4.4.2 Ocular motility (Visit 1) 
Ocular motility testing, or the Broad H test, provides insight into the integrity of the six extra-
ocular muscles and their nerve supply.39 During this test, participants were asked to track a 
moving target with their eyes while the examiner watches the eyes to observe for any irregular 
eye movements. The target used in this test was a black (z) letter, printed in 14-point font size 
on white paper and glued to a stick that was held at a 40cm test distance. The examiner moved 
the target into the six cardinal gaze positions (in the form of an (H) shape) while observing the 
participants’ eye movements. Any irregular eye movements in the form of jerky eye movements, 
overactions, or underactions were recorded with the accompanied position of gaze.  
A scale of -1 (lowest) to -4 (greatest) was given to mark the degree of underaction of the eye 
movements. Conversely, a scale of +1 (lowest) to +4 (greatest) was given to mark the degree of 
overaction of the eye movements. If there was no underaction or overaction of the eye 
movements, a score of 0 was given. Reported symptoms such as double vision or discomfort in 
any of the six-cardinal positions were also recorded. 
2.4.4.3 Stereopsis (Visit 1) 
Stereopsis, or depth perception, is a fundamental component of binocular vision. Under normal 
binocular viewing conditions, the visual system captures two images (one from each eye). 
These two images are slightly different due to the fact that the human eyes are separated 
horizontally. The outcome of this disparity is binocularly detectable patterns and perceived 
depth.51 Stereopsis measures the ability of the visual system to combine the two monocular 
images to form a single three-dimensional, binocular view of the environment.51,52 There are two 
stereopsis mechanisms in the visual system; local and global stereopsis.51 Local stereopsis 
depends on horizontally separated patterns that are detectable with monocular viewing. Global 
stereopsis is a binocularly detectable pattern that cannot be detected when viewed monocularly.  
Global and local stereopsis were measured in this study using the Randot stereo-acuity test at 
40 cm. The test was repeated three times and the average stereopsis was calculated in 
seconds of arc. 
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2.4.4.4 Accommodative function 
2.4.4.4.1 Amplitude of accommodation (Visit 1) 
Accommodation is the ability of the eye to obtain focus on targets over a large range of 
distances. Amplitude of accommodation (AA) is a visual function that normally decreases with 
age.39,53 There are several techniques to quantify AA and it is measured in diopter units (D).  
The pull-away technique was used in this study and values were measured with the Royal Air 
Force (RAF) rule. The RAF rule is a standard tool for measuring near visual functions such as 
accommodation. It consists of 50 cm rule with a movable and rotatable cube. The cube has four 
sides each with different viewing targets. For this test, the chosen target was one line better 
than the participant’s near VA. Initially, the participant was asked to close both eyes. The eye 
not being tested was covered with an eye patch. Then, the target was placed close to the 
participant’s eyes, in front of the eye being tested. After that, the participant was asked to open 
the uncovered eye and look at the target; if the target was blurry it was pulled away until the 
participant reported the target was clear. The distance from the participant to the target was 
measured and recorded as the test endpoint in dioptric units. The test was conducted 
monocularly and repeated three times for each eye.  
The minimum AA expected based on age was calculated using the Duane-Hofstetter formula: 
minimum AA= 15.0 – 0.25 x age. Then, the resultant AA value was calculated by subtracting the 
minimum AA expected based on age from the participant’s average measured AA. If the total 
was positive that indicated better AA average than expected for the participant’s age and vice 
versa. Additionally, the monocular difference in accommodation between the two eyes was 
measured by calculating the absolute difference of the AA (|OD – OS|). This method was 
followed since there is a lack of established normative data on the pull-away technique in the 
literature to rely on. 
2.4.4.4.2 Accommodation accuracy (Visit 1) 
In daily life activities, accommodation of the eyes is needed to perform different near tasks such 
as reading and writing. For these kinds of tasks, some eyes exert more accommodation (lead) 
than needed, while others produce an insufficient amount of accommodation (lag). 
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Accommodation accuracy is an eye test that determines the individual’s accommodative posture 
when performing a near task.39,50 
Accommodation accuracy can be tested with different methods. In this study, the Monocular 
Estimated Method (MEM) was conducted using a Welch Allyn fixation card attached to a 
retinoscope at the examiner’s working distance of 54 cm. Room lighting was decreased by two-
thirds for all participants to allow for better observation of the light reflection in the eye being 
tested while ensuring participants could still view the words on the card. Participants were asked 
to read the words on the card out loud, while the examiner performed MEM retinoscopy and 
neutralised the retinal reflex seen. The result was recorded as the dioptric power of the lens 
needed to neutralize the light reflex in each eye. A plus value indicated a lag of accommodation 
and a minus value indicated lead of accommodation. Additionally, the monocular difference in 
accommodation accuracy between the two eyes was measured by calculating the absolute 
difference of the accommodation accuracy (|OD – OS|). 
2.4.4.4.3 Accommodation facility (Visit 1) 
An individual’s ability to rapidly change focus is called accommodation facility (AF). This 
characteristic has been determined to be related to other vision symptoms especially those 
associated with near tasks.39 Scientists have concluded that accommodation facility is an 
independent measure which means ‘accommodation infacility’ can occur even with normal 
results on other accommodation tests.39  
A  2.00 diopter lens flipper was used in this test. Participants were instructed to place the Bee 
near VA chart at a 40 cm distance and focus on the line above their best near VA. Participants 
were instructed to try to make the target clear when one of the lenses was placed in front of the 
eye, and report when the target was clear by saying ‘clear’. Then, the lenses were “flipped” and 
the opposite lens was presented. The process continued for one minute and the number of 
cycles completed was recorded. A cycle was counted when the participants report a clear target 
for both lenses. This test was performed monocularly. Each eye was tested three times and the 
average was calculated and recorded in cycles per minute (cpm) units. Additionally, the 
monocular difference between the two eyes was measured by calculating the absolute average 
facility difference (|OD – OS|). 
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2.4.4.4.4 Negative relative accommodation (NRA) and positive relative accommodation 
(PRA) (Visit 1) 
Negative and positive relative accommodation tests determine the accommodation range of the 
individual relative to their vergence function.54 Along with other accommodation tests, NRA and 
PRA give insight into the accommodation system and its function.54,55 Individual’s ability to relax 
accommodation is examined with NRA and PRA tests the individual’s ability to exert 
accommodation.54  
The target used in this test was one line better than the participant’s near VA using the near Bee 
VA chart at 40 cm. First, the NRA test was performed with a plus lens bar placed in front of the 
participant’s eyes to avoid the influence of accommodation on the measurement. Participants 
were asked to keep the target clear while examiner gradually increased the power of the lenses 
and to report when the target was blurry. Then, the PRA test was performed with a negative 
lens bar and the same instructions were given. The PRA and NRA test results were recorded as 
the dioptric power of the first lens that caused sustained blur. 
2.4.4.5 Vergence function 
2.4.4.5.1 Near point of convergence (Visit 1) 
Vergence is a voluntary eye movement. It involves either a convergence or a divergence of the 
eyes’ visual axes to maintain a single image while focusing on a near or distance target.39,50 
When performing a near task, three ocular responses take place; convergence, 
accommodation, and pupil constriction.39,50 The near point of convergence (NPC) is the point 
where the visual axes intersect under the maximum effort of convergence while maintaining 
single vision.39,50  
In this study, the RAF rule was used to measure NPC. The target was a vertical line with a 
central black dot. Participants were asked to focus on the black dot and report when the dot split 
into two or went double (break point), and then when the black dot became single again 
(recovery point). The break point was measured when either the participant reported seeing the 
black dot doubled (subjective NPC) or when the examiner observed the eye drifted out 
(objective NPC); the recovery point was measured when the participant reported seeing the 
 
20 
black dot single again. Break and recovery points were measured in centimeters (cm). The test 
was repeated three times and the average was calculated. Also, the difference between the two 
points was calculated (recovery point - break point). 
In the literature, there is diversity around the normative data for NPC based on the population 
studied and the target used when testing NPC.39,50,56,57 There tends to be an agreement that 
NPC in adults should be about 7 cm and 10 cm for break and recovery points, respectively. 
2.4.4.5.2 Fusional reserve (Visit 1) 
Fusional reserve (FR) is also known as fusional amplitude, and is the amount of prism power 
the eyes can tolerate while still maintaining single vision before fusion breaks, resulting in 
double vision.39,50 Fusional reserve can be assessed at distance and at near, both horizontally 
(H) and vertically (V). The ability of the eyes to overcome the power of base-out or base-up 
prism over the right eye is known as positive fusional reserve (PFR). Negative fusional reserve 
(NFR) is obtained with base-in or base-down prism over the right eye.39,50 
This test was performed binocularly using hand-held prism bars to introduce prisms in front of 
one eye. Distance (6m) PFR and NFR were measured using the 6/12 line of the EDTRS chart 
printed on A4 paper as a target. Near (40cm) PFR and NFR were measured using isolated lines 
of a near Hart card (approximately 0.50 M size). The FR assessment was conducted both 
horizontally and vertically at both distances. A vertical target was used for the horizontal FR 
testing and a horizontal target was used for the vertical FR testing. Participants were instructed 
to look at the target and report when it got blurry, double, and single again. The resultant prism 
in front of the eye at each point (blur, double, and single) was recorded in prism diopters (PD). 
2.4.4.5.3 Vergence facility (Visit 1) 
As described earlier, there are two types of vergence eye movements: convergence and 
divergence. Tests of vergence facility are designed to examine the ability of the vergence 
system to perform rapid convergence and divergence eye movements over a specific period of 
time.39,50 This test is conducted by placing prisms of different powers and base directions in front 
of one eye (under binocular conditions) to stimulate the two different vergence eye movements. 
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In addition to the fusional reserves vergence test, vergence facility testing is useful in 
diagnosing binocular vision problems.39,50 
A 3 base-in / 12 base-out prism flipper was used in this study, and the target was an isolated 
vertical line from a near Hart chart card at a 40 cm distance. The test began with placing the 3 
base-in prism in front of the right eye. Participants were asked to report if the target was seen as 
one, by saying ‘single’; if the target was seen as double, participants were encouraged to try 
and make it single, and then to report when it was single. Once the target was seen as single 
with the 3 base-in prism in place, then a 12 base-out prism was introduced and the participant 
was asked to indicate when the line was single again. The test continued for one minute, and 
successful target fusion of both prisms was considered as one cycle; the number of completed 
cycles was recorded. The test was repeated three times and the average was calculated and 
recorded in cycles per minute (cpm) units. 
2.4.5 Global visual function 
2.4.5.1 Visual spatial awareness - cyclopean eye alignment position (Visit 1) 
Conventionally, binocular visual direction was believed to be the average of the visual direction 
from both eyes. Currently, scientists determined that binocular visual direction originates from a 
reference point that falls midway between the eyes; the cyclopean eye (CE).58–60 In other words, 
the CE provides a unified visual direction using the information from both eyes. The assessment 
of visual direction is important because individuals with head injuries have demonstrated shifts 
in their perceptions of visual direction.61  
A rod with a 50 cm length and a 4 mm diameter was placed 50 cm from the bridge of the 
participant’s nose. The rod was rotated from the participant’s right side on the 180 plane (Figure 
2-1),58 and the participant was asked to say ‘stop’ when the rod was centred. Then, a picture 
was taken from above the instrument to determine the visual direction angle; however, after 
testing a few participants the examiner noted that the measurement could be improved. 
Therefore, a printed protractor was centred underneath the rod to specify the visual direction 
angle. The test was repeated three times and the average was calculated in degree units. 
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Figure 2-1: Cyclopean eye alignment position instrument 
 
 
2.4.5.2 King-Devick (Visit 1) 
The King-Devick (KD) test is a neuropsychological test that is based on measuring the speed of 
rapid number naming. The KD test examines suboptimal brain function by detecting deficits of 
language, eye movements, and attention.62,34 Research studies determined that the KD test is a 
useful tool for concussion screening.62,34 In this study, a software version of the KD test was 
used on an iPad (Figure 2-2). The KD test consists of three cards of numbers arranged in 
different configurations. Participants were asked to hold the iPad at a distance of 40 cm and 
read each of the three test cards as fast and accurate as possible. The total time to read all 
three cards was automatically measured by the iPad and recorded on the testing sheet. The 
number of errors participants made was also recorded. Errors were based on participant’s first 
response, and an error was recorded if the participant skiped or misnamed a number. 
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Figure 2-2: King-Devick (KD) test on iPad 
 
2.4.5.3 Visual motor integration 
2.4.5.3.1 Visual-motor reaction time (Visit 2) 
Visual-motor reaction time (VMRT) is defined as the time the visual system requires to process 
a visual stimulus plus the time needed from the neuromuscular motor system to give a motor 
response for that particular stimulus.63 
In this study, an eye-hand reaction time test was used to assess the VMRT. Despite the fact 
that eye-hand coordination has been studied in different contexts such as sports, there is a lack 
of a standardized and validated tools to examine eye-hand reaction time.64 The Sports Vision 
Trainer (SVT) is a tool that has been developed by scientists at The New South Wales Institute 
of Sport in Sydney, Australia to measure eye-hand reaction time (Figure 2-3).65 Scientists have 
established the test-retest reliability of the specific SVT protocol that was followed in this 
study.64 
The SVT board is about 114 cm height and 125 cm width, and rests on a height adjustable 
table. The board consists of a matrix of 80 circular lights targets. Each light target consists of a 
touch pad (2 cm diameter), centered in a circle (8 cm diameter). 
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Participants were asked to stand in front of the reaction time board at a distance where they 
could easily reach the side, lower, and upper lights. The board’s height was then adjusted to be 
in line with the participant’s eye level in primary gaze. 
The test was run in proactive mode, which means the light stayed on the board until the 
participant responded by hitting it. Central and peripheral reaction times were each assessed 
with 4 trials (one practice and three test trials). The lights were shuffled before starting each trial 
so the lights appeared in a randomized manner. The total reaction time was recorded in 
milliseconds (ms) for each trial. The average reaction time per light was calculated based on the 
three test trials only (ignoring the practice trial). All results were automatically saved by the SVT 
software and exported for analysis. 




2.4.5.3.2 Coincidence anticipation timing (Visit 2) 
Coincidence anticipation timing (CAT) is defined as the ability to judge when a moving object 
will arrive at a designated point.63,66 CAT is a cognitive task that incorporates different parts of 
the brain to deliver the required response.63,66–68 The task involves a combination of visual input 
processing, decision making, and motor response delivery.66–68 Hence, it has the potential to 
provide significant insight into both brain function and cognitive capability.66 The Bassin 
Anticipation Timer (BAT) is a common application used in clinical research to assess 
coincidence anticipation timing. The BAT consists of a long track of light-emitting diodes (LEDs) 
that can be programmed to travel at different speeds and trajectories (i.e. constant motion or 
acceleration).63 
Figure 2-4: Bassin Anticipation Timer (BAT) 
 
Participants were asked to respond by pressing a button when they thought the light would 
arrive at a specific location on the track. For this study, the test was designed so that the light 
traveled with a constant motion at speeds ranging from 5mph to 40mph (in 5mph steps). Each 
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speed presentation was repeated for 5 trials before the next speed was presented. The 5 
repeated trials were used to compute 3 different average error values as follows: 1) Constant 
error (CE) which provided a measure of how early (positive value) or late (negative value) the 
participant tended to respond on average, 2) Absolute error (AE) which was an average of the 
absolute error magnitude, and 3) Variable error (VE) which provided a measure of the average 
variability of the accuracy values across all 5 trials. 
2.5 Statistical analysis 
Overall, normal distribution of the data was tested using the Shapiro-Wilk test with SPSS 
analysis software (Version 25, New York, USA). The data was not normally distributed in the 
majority of tests; therefore, non-parametric analysis tests were chosen. All data were analyzed 
using non-parametric analyses, and no additional data transformations were performed on the 
data that was normally distributed prior to analysis.  
2.5.1 Descriptive statistics and group comparison 
The study data was presented as the descriptive statistics (mean, standard deviation (SD), and 
median) of each visual function for each group. Descriptive statistics were calculated with 
Microsoft Office Excel software (Version 16.16.2, Redmond, USA). Additionally, scatter plots 
were presented for visual inspection of all the data. All scatter plots were graphed using 
GraphPad Prism software (Version 7.0d, La Jolla, USA), and all the correlation plots were 
graphed using RStudio (Version 1.1.456, Boston, USA).    
A Mann Whitney U-test was conducted to identify the difference in symptoms and visual 
functions between the two groups using SPSS. Statistical test results were presented as level of 
significance represented by the p-value. All p-values <0.05 were considered to be significant.  
2.5.2 Correlation analysis  
A Spearman non-parametric correlation test was conducted with SPSS to examine the 
correlation between symptom severity and visual functions in both study groups. Correlations 




 - Results: Comparison of Control and PCS groups 
3.1 Sample 
Forty-four participants aged 18 to 35 years old were recruited for, and successfully completed 
the two study visits. The study participant groups are as follows: 1) Healthy participants with no 
history of concussion (Controls; n=33), and 2) Participants with PCS (n=11). One PCS 
participant was excluded from data analysis for not meeting the inclusion criteria, therefore 
(n=10) participants were included in the PCS group for analysis purposes. All PCS participants 
were athletes who played recreational sports (n=3) or varsity sports (n=7). Sixteen control 
participants were athletes, and all but one of these participants played recreational sports. The 
remaining 17 control participants did not play any sports (Table 3-1).  
3.2 Test battery feasibility  
The test battery appears to be feasible in both the control and PCS group. All participants 
successfully completed all of the tests in the battery and the two study visits and no participants 
withdrew from the study. While all of the participants enrolled in the study were able to complete 
the test battery, many of the PCS participants took more time than expected to complete the 
battery because their symptoms were exacerbated by some of the tests conducted. While this 
finding suggests that the test battery was not actually feasible in the PCS population, the 
examiner would disagree, because the symptom exacerbation triggered by certain tests in the 
battery is an interesting finding of itself. The PCS participant’s symptom exacerbation during 
testing will be discussed further in Section 4.7. 
3.3 Health history questionnaire 
As mentioned in the Methods chapter, participants were asked to complete health history 
questionnaires to gain an insight on the participants’ well-being, activity levels, and symptoms 
on the days of testing. For the purpose of this thesis, the number of symptoms reported, the 
severity of symptoms reported, and the number of previous concussions (in the PCS group 
only) were examined (Tables 3-2 and 3-3). Overall, participants were healthy; no participants 
reported a history of an eye problem or manifest binocular vision problem that would have 
excluded them from participation in this study. 
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Table 3-1: Overview of demographic data of the control and PCS group 
Group Controls (n=33) PCS (n=10) 
Gender 









Level and type of sports 
Recreational sports (n=15) 
Badminton, swimming, 
tennis, Muay Thai, yoga, rock 
climbing, hockey, baseball, 
skating, volleyball, and 
soccer. 
Recreational sports (n=3) 
Skiing, soccer, and hockey. 
Varsity sports (n=2) 
Cricket, field hockey 
Varsity sports (n=6) 
Rugby, swimming, 





Sport practice (hr/week) 
Mean ± SD 3.8 ± 3.6 
Only 3 PCS participants 
reported their sport practice 
(hr/week) as 2,5, and 6, 
respectively.  
One participant reported 
sport activity cessation since 
the concussion incident. The 
rest of the group reported 








Participant symptoms were assessed using the health history questionnaire in two ways: 1) a 
total number of symptoms and 2) a symptom severity score. Participants were asked to score 
their symptoms on a 7-point Likert scale ranging from 0 (no symptoms) to 6 (severe symptoms) 
based on how they felt “now” at each study visit. Each symptom scored at a value of 1 or more 
was counted as symptom. The total number of symptoms that could be reported was 22 
symptoms. Symptom severity score was calculated by summing up all of the individual severity 
scores across all 22 symptoms. Symptom severity score had minimum value of 0 and a 
maximum value of 132 (Table 3-2). 
As expected, the PCS group reported more symptoms than the control group at both visits 
(p<0.0001; Table 3-2). The PCS group also reported more severe symptoms than the control 
group at both visits (p<0.0001; Table 3-2). It is interesting to note that, despite the control group 
not having any history of concussion, some participants in the control group reported 
experiencing some level of symptoms, as shown in (Table 3-2). While the presence of 
symptoms in the control group was an interesting finding, it was not unexpected. The symptoms 
assessed with the health history questionnaire are not concussion specific and it is not 
uncommon for healthy, non-concussed university students to routinely demonstrate some of 
these symptoms. 
Although the analysis in this study was done considering both symptom measures, number of 
symptoms and symptom severity scores, the primary measure of participant’s symptoms 
chosen for the purpose of this thesis was the symptom severity score. From the descriptive 
statistics presented below (Table 3-2, Figures 3-1 and 3-2), it is obvious that symptom severity 
values were more prominent in the PCS group. Also, symptom severity appeared to change 
more between study visits, especially in the PCS group, and the examiner felt that the changes 
in symptom severity scores better represented participant’s symptoms on each day of testing, 
which was important for the correlation analysis between symptoms and visual functions. For 
these reasons, symptom severity was prioritized over the number of symptoms. The examiner 
recognizes that analyses based on symptom severity are limited to some extent as symptom 
severity scores are subjective and have a greater scale (score out of 132) than the number of 
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symptoms (score out of 22), however this was still the metric chosen for use in this particular 
analysis. 
Please note, in all of the tables presented below, p-values marked with a * are significant at 
least p<0.05. On all the presented scatter plots, ● = control group data, and ▲ = PCS group 
data, unless specified otherwise. 
Table 3-2: Symptom data of the control and PCS group at visits 1 and 2 
 Mean SD Median p-value 
Number of Symptoms 
Control – visit 1 3.5 4.8 1 
<0.0001 
PCS – visit 1 13.8 4.6 15 
Control – visit 2 2.8 4.1 1 
<0.0001 
PCS – visit 2 13.2 6.3 11.5 
Symptom Severity 
Control – visit 1 6.8 11.0 2.0 
<0.0001 
PCS – visit 1 39.4 24.0 39.5 
Control – visit 2 4.3 6.8 1.0 
<0.0001 
PCS – visit 2 28.4 21.3 19.5 
 




Figure 3-2: Number of symptoms scatter plot 
 
3.3.2 Number of previous concussions (PCS group) 
In addition to assessing the number of symptoms participants experienced as well as the 
severity of symptoms experienced, all participants in the PCS group were asked to report how 
many previous concussions they had had (Table 3-3). On average participants had 3.9 previous 
concussions (range 1 to 11 previous concussions). 
Table 3-3: Previous concussions data (PCS group) 




3.4 Comparing visual function between groups 
A Mann Whitney U-test was conducted to identify differences in visual function performance 
between the control and the PCS groups. The p-values of all test comparisons are presented, 
along with the descriptive statistics (mean, standard deviation (SD), median values) in the tables 
below. In addition, scatter plots and/or graphs of all tests are presented.  
Overall, there was no statistically significant differences in performance between the two groups 
on any of the visual functions measured except for the following tests: King-Devick test 
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(p=0.04), cyclopean eye test (p=0.03), and peripheral visual-motor reaction time test (p=0.04). 
Further information about all of the visual function tests completed is presented in the following 
sections. 
3.4.1 Static visual perception 
3.4.1.1 Static distance visual acuity 
There was no statistically significant difference in static distance visual acuity between the two 
groups in OD (p=0.54), OS (p=0.64), or OU (p=0.97). Although not compared statistically, the 
SD values of both groups also appear to be similar for OD, OS, and OU. 
Table 3-4: Distance static visual acuity (4m; logMAR) 
 Eye tested Mean SD Median p-value 
Control 
OD 
-0.04 0.13 -0.08 
0.54 
PCS -0.03 0.10 -0.06 
Control 
OS 
-0.04 0.10 -0.08 
0.64 
PCS -0.02 0.07 0.00 
Control 
OU 
-0.11 0.10 -0.16 
0.97 
PCS -0.13 0.05 -0.13 
 




3.4.1.2 Static near visual acuity 
There was no statistically significant difference in static near visual acuity between the two 
groups in OD (p=0.62), OS (p=0.44), or OU (p=0.64). Although not compared statistically, the 
PCS group’s performance appeared to be less consistent than the control group, as 
demonstrated by the larger SD values. This observation was particularly apparent in the OU 
data.  
Table 3-5: Near static visual acuity (40 cm; M unit) 
 Eye tested Mean SD Median p-value 
Control 
OD 
0.42 0.04 0.40 
0.62 
PCS 0.44 0.08 0.40 
Control 
OS 
0.40 0.02 0.40 
0.44 
PCS 0.42 0.04 0.40 
Control 
OU 
0.40 0.00 0.40 
0.64 
PCS 0.41 0.03 0.40 
 





3.4.1.3 Contrast sensitivity 
There was no statistically significant difference in the contrast sensitivity between the two 
groups in contrast sensitivity (p=0.60). Based on visual evaluation there was also no difference 
between the SD values of both groups. 
Table 3-6: Contrast sensitivity (1m; logCS) 
 Eye tested Mean SD Median p-value 
Controls 
OU 
2.00 0.06 1.99 
0.60 
PCS 1.99 0.11 2.02 
 
Figure 3-5: Contrast sensitivity scatter plot 
 
 
3.4.2 Dynamic visual perception 
3.4.2.1 Dynamic distance visual acuity 
There was no statistically significant difference in the dynamic distance visual acuity between 
the two groups in horizontal (p=0.89), jitter (p=0.68), and random (p=0.12) motions. The SD 
values of both groups also appear to be similar based on visual inspection, except for the 
random motion task on which controls appeared to demonstrate greater variability. 
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Table 3-7: Dynamic distance visual acuity (4m; logMAR) 
 Motion type Mean SD Median p-value 
Controls 
Horizontal 
0.08 0.12 0.00 
0.89 
PCS 0.06 0.10 0.05 
Controls 
Jitter 
-0.13 0.12 -0.10 
0.68 
PCS -0.15 0.10 -0.20 
Controls 
Random 
0.13 0.17 0.10 
0.12 
PCS 0.04 0.10 0.10 
 
Figure 3-6: Dynamic distance visual acuity scatter plot 
 
 
3.4.3 Refractive status 
3.4.3.1 Objective refraction 
There was no statistically significant difference in the objective refraction spherical equivalent 
between the two groups in either the right (p=0.20) or left eyes (p=0.37). The lack of statistical 
difference between the two groups was probably due to the high variability of this parameter in 




Table 3-8: Objective refraction (spherical equivalent; D) 
 Eye tested Mean SD Median p-value 
Controls 
OD 
-2.70 3.50 -1.12 
0.20 
PCS -0.92 1.34 -0.44 
Controls 
OS 
-2.60 3.40 -0.75 
0.37 
PCS -1.00 1.45 -0.40 
 
Figure 3-7: Objective refraction (spherical equivalent) scatter plot 
 
3.4.4 Binocular vision 
3.4.4.1 Ocular alignment 
For the ocular alignment tests, no tropia (strabismus) was found in either group. The ocular 
misalignment findings that were present included exophoria (represented by a minus sign), 
esophoria (represented by a plus sign), or orthophoria (represented by zero). 
3.4.4.1.1 Distance ocular alignment  
There was no statistically significant difference in the mean distance ocular misalignment test 
between the two groups in primary (p=0.72), left (p=0.60), or right (p=0.40) gazes. Visual 
observation suggests that both the SD and median values of both groups were also similar. 
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Table 3-9: Distance ocular alignment (4m; PD) 
 Gaze Mean SD Median p-value 
Controls 
Primary gaze 
-0.6 2.2 0.0 
0.72 
PCS -0.7 1.9 0.0 
Controls 
Left gaze 
-0.6 1.8 0.0 
0.60 
PCS -0.7 1.9 0.0 
Controls 
Right gaze 
-0.5 2.0 0.0 
0.40 
PCS -1.1 2.1 0.0 
 
Figure 3-8: Distance ocular alignment scatter plot 
 
3.4.4.1.2 Near ocular alignment 
There was no statistically significant difference in the mean near ocular misalignment test 
between the two groups in primary (p=0.14), left (p=0.18), or right (p=0.18) gazes. Based on 
visual inspection, there does not appear to be a difference in SD values between groups, 
however, visual inspection of the median values suggests that there was more exophoria in the 




Table 3-10: Near ocular alignment (40cm; PD) 
 Gaze Mean SD Median p-value 
Controls 
Primary gaze 
-1.1 3.3 0.0 
0.14 
PCS -2.7 2.9 -2.5 
Controls 
Left gaze 
-1.3 3.1 0.0 
0.18 
PCS -2.7 2.9 -2.5 
Controls 
Right gaze 
-1.3 3.1 0.0 
0.18 
PCS -2.7 2.9 -2.5 
 
Figure 3-9: Near ocular alignment scatter plot 
 
3.4.4.2 Ocular motility 
As described in the methods chapter, ocular motility assessment was performed using the 
Broad H method. All the control participants in addition to seven participants of the PCS group 
had normal eye movements with no observed abnormalities or reported symptoms. Only three 
participants from the PCS group had abnormal findings as described in the following sections. 
3.4.4.2.1 Participant 1 
This participant had restricted binocular eye movements in the upper left and right cardinal 
gazes. Also, nystagmus was noted in both eyes in the upper left and right cardinal gazes only.  
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The nystagmus was accompanied with eyeball strain, forehead pain, and headache reported by 
the participant. 
Figure 3-10: Ocular motility test result - Participant 1 
  
3.4.4.2.2 Participant 2 
This participant had restricted eye movement in all six cardinal positions. In the upper and 
middle positions, the restricted eye movements were graded as (-2) for both left and right sides. 
However, in the lower left and right cardinal positions, the eye movement restrictions were 
recorded as (-1). This participant reported symptoms of headache, irritation, and difficulty in 
concentrating on the target while moving their eyes.  
Figure 3-11: Ocular motility test - Participant 2 
  
3.4.4.2.3 Participant 3 
This participant had no restricted eye movements. However, the participant had jerky eye 
movements while following the target in all positions of gaze. Furthermore, the participant 
reported the target appeared to be flickery throughout the test. 
3.4.4.3 Stereopsis 
There was no statistically significant difference in the stereopsis test between the two groups 
(p=0.45). Visual inspection of the SD values suggests that the variability in stereopsis was also 
similar between the two groups. 
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Table 3-11: Stereopsis (40cm; arc sec) 
 Mean SD Median p-value 
Controls 30.3 16.8 22.7 
0.45 
PCS 34.0 18.6 25.0 
 
Figure 3-12: Stereopsis scatter plot 
 
3.4.4.4 Accommodation function 
3.4.4.4.1 Amplitude of Accommodation 
There was no statistically significant difference in the amplitude of accommodation between the 
two groups in OD (p=0.31), OS (p=0.52), or the absolute difference between the two eyes 





Table 3-12: Amplitude of accommodation (40cm; D) 
 Eye tested Mean SD Median p-value 
Control 
OD 
0.8 1.8 0.8 
0.31 
PCS 1.4 1.7 1.3 
Control 
OS 
1.2 2.0 0.8 
0.52 
PCS 1.5 2.0 1.3 
Control Absolute 
difference 
0.8 0.8 0.7 
0.21 
PCS 0.5 0.6 0.3 
 






Figure 3-14: Amplitude of accommodation (absolute difference) scatter plot 
 
 
3.4.4.4.2 Accommodation accuracy 
There was no statistically significant difference in the accommodation accuracy between the two 
groups in OD (p=0.84), OS (p=0.41), or the absolute difference (p=0.14) between the two eyes. 
Also, visual inspection suggested that the SD values of both groups were similar. However, 
there were three PCS participants who demonstrated abnormal behavior on this test by having 
one eye with lag (plus value) and the other eye with lead (minus value) of accommodation as 
shown in the scatter plot (Figure 3-16). Conversely, this abnormality was not found in the control 




Table 3-13: Accommodation accuracy (54cm; D) 
 Eye tested Mean SD Median p-value 
Control 
OD 
0.63 0.57 0.75 
0.84 
PCS 0.70 0.71 0.75 
Control 
OS 
0.56 0.51 0.50 
0.41 
PCS 0.80 0.68 0.75 
Control Absolute 
difference 
0.14 0.18 0.25 
0.14 
PCS 0.38 0.41 0.25 
 




Figure 3-16: Accommodation accuracy scatter plot for the PCS group 
 
 





3.4.4.4.3 Accommodation facility 
There was no statistically significant difference in the accommodation facility between the two 
groups in OD (p=0.37), OS (p=0.48), or in the absolute difference between the two eyes 
(p=0.61). The SD values of both groups appear to be similar upon visual inspection. 
Table 3-14: Accommodation facility (40cm; cpm) 
 Eye tested Mean SD Median p-value 
Control 
OD 
9.9 6.4 9.3 
0.37 
PCS 7.7 6.4 9.7 
Control 
OS 
11 6.8 11.0 
0.48 
PCS 9.4 6.1 10.3 
Control Absolute 
difference 
2.4 2.5 1.7 
0.61 
PCS 2.0 2.2 1.0 
 





Figure 3-19: Accommodation facility (absolute difference) scatter plot 
 
3.4.4.4.4 Negative and positive relative accommodation 
This test was added to the testing protocol part way through the study. Therefore, there were 
fewer participants who completed this test (control n=10, PCS n=8).  
There was no statistically significant difference in the NRA (p=0.60) and PRA (p=0.81) values 
between the two groups, and visual inspection of the SD values of these measures suggest that 
the variability of the results in both groups was similar.  
Table 3-15: Negative and positive relative accommodation (40cm; cpm) 
 Test N Mean SD Median p-value 
Control 
NRA 
10 2.6 0.7 3.0 
0.60 
PCS 8 2.7 0.7 2.0 
Control 
PRA 
10 -3.3 1.8 -3.0 
0.81 
PCS 8 -3.8 1.8 -3.8 
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Figure 3-20: Negative relative accommodation scatter plot 
 
 





3.4.4.5 Vergence function 
3.4.4.5.1 Near point of convergence 
There was no statistically significant difference in the near point of convergence between the 
two groups in break (p=0.99) and recovery (p=0.83) points, and in the difference between the 
two points (p=0.34). Visual inspection of the SD values of both groups suggests that the 
variability in each group was similar. 
Table 3-16: Near point of convergence (40cm; cm) 
  Mean SD Median p-value 
Control 
Break point 
5.3 2.9 5.3 
0.99 
PCS 5.4 2.7 6.0 
Control 
Recovery point 
6.4 3.3 7.0 
0.83 
PCS 6.9 3.1 7.6 
Control 
Difference 
1.1 0.9 1.1 
0.34 
PCS 1.5 0.9 1.4 
 





Figure 3-23: Near point of convergence (difference) scatter plot 
 
 
3.4.4.5.2 Distance horizontal positive fusional reserve 
There was no statistically significant difference in the distance HPFR between the two groups in 
blur (p=0.62), double (p=0.40), or recovery (p=0.48) points. Although not tested statistically, 
there does not appear to be a difference in SD values between groups, except in the double 
point where the PCS group appears do demonstrate slightly more variability. Interestingly, 
based on visual inspection of the median values, the PCS group appear to perform better than 
the controls across all points. 
Table 3-17: Distance horizontal positive fusional reserve (4m; PD) 
  Mean SD Median Min Max p-value 
Control 
Blur point 
7.2 7.0 6.8 0 20 
0.62 
PCS 8.6 7.0 8.0 0 20 
Control 
Double point 
20.0 7.3 19.6 6 30 
0.40 
PCS 23.0 10.9 25.0 8 35 
Control 
Recovery point 
14.7 7.0 14.7 2 25 
0.48 
PCS 16.4 6.6 16.4 6 25 
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Figure 3-24: Distance horizontal positive fusional reserve scatter plot 
 
3.4.4.5.3 Distance horizontal negative fusional reserve 
There was no statistically significant difference in the distance HNFR between the two groups in 
blur (p=0.62), double (p=0.56), and recovery (p=0.77) points. Also, both the SD and median 
values of these measures appear to be similar between the groups based on visual inspection.  
Table 3-18: Distance horizontal negative fusional reserve (4m; PD) 
  Mean SD Median p-value 
Control 
Blur point 
1.6 3.0 0.4 
0.62 
PCS 0.5 1.3 0.2 
Control 
Double point 
7.6 2.8 7.6 
0.56 
PCS 7.0 2.7 6.6 
Control 
Recovery point 
5.3 2.6 5.1 
0.77 
PCS 5.0 2.7 4.6 
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Figure 3-25: Distance horizontal negative fusional reserve 
 
 
3.4.4.5.4 Distance vertical positive fusional reserve 
There was no statistically significant difference in the distance VPFR between the two groups in 
double (p=0.77), and recovery (p=0.78) points. Both the SD and median values of these 
measures appear to be similar between the groups based on visual inspection.  
Table 3-19: Distance vertical positive fusional reserve (4m; PD) 
  Mean SD Median p-value 
Control 
Double point 
3.2 1.2 3.0 
0.77 
PCS 3.4 2.6 3.0 
Control 
Recovery point 
1.9 1.0 1.7 
0.78 
PCS 2.3 2.3 2.0 
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Figure 3-26: Distance vertical positive fusional reserve 
 
 
3.4.4.5.5 Distance vertical negative fusional reserve 
There was no statistically significant difference in the distance VNFR between the two groups in 
double (p=0.89), and recovery (p=0.99) points. The SD and median values of both groups also 
appear to be similar based on visual inspection. 
Table 3-20: Distance vertical negative fusional reserve (4m; PD) 
  Mean SD Median p-value 
Control 
Double point 
2.6 1.3 2.5 
0.89 
PCS 2.8 2.2 2.5 
Control 
Recovery point 
1.5 0.9 1.4 
0.99 
PCS 1.7 1.9 1.5 
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Figure 3-27: Distance vertical negative fusional reserve scatter plot 
 
 
3.4.4.5.6 Near horizontal positive fusional reserve 
There was no statistically significant difference in the near HPFR between the two groups in blur 
(p=0.85), double (p=0.72), and recovery (p=0.38) points. Visual inspection of the median values 
also suggests that the groups behaved similarly. However, based visual inspection of the SD 
values, the PCS group appeared to demonstrate more variability than the control group, as the 
standard deviation of the mean was larger in the PCS group than the control group.  
Table 3-21: Near horizontal positive fusional reserve (40cm; PD) 
  Mean SD Median p-value 
Control 
Blur point 
3.9 6.6 0.6 
0.85 
PCS 8.1 8.9 7 
Control 
Double point 
17.6 9.1 17.0 
0.72 
PCS 15.8 11.7 15.0 
Control 
Recovery point 
12.8 7.2 14.3 
0.38 
PCS 13.5 10.3 13.0 
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Figure 3-28: Near horizontal positive fusional reserve scatter plot 
 
 
3.4.4.5.7 Near horizontal negative fusional reserve 
There was no statistically significant difference in the near HNFR between the two groups in blur 
(p=0.85), double (p=0.72), and recovery (p=0.39) points. There were no obvious differences in 
the SD or median values of both groups upon visual inspection of these values either. 
Table 3-22: Near horizontal negative fusional reserve (40cm; PD) 
  Mean SD Median p-value 
Control 
Blur point 
3.4 5.59 0.6 
0.85 
PCS 3.8 6.14 2.0 
Control 
Double point 
12.3 4.38 12.0 
0.72 
PCS 13.5 6.16 12.0 
Control 
Recovery point 
9.9 4.1 9.7 
0.39 
PCS 11.6 5.5 11.3 
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Figure 3-29: Near horizontal negative fusional reserve 
 
 
3.4.4.5.8 Near vertical positive fusional reserve 
There was no statistically significant difference in the near VPFR between the two groups in 
double (p=0.56) and recovery (p=0.45) points. While not tested statistically, the SD and median 
values of both groups also appear to be similar.  
Table 3-23: Near vertical positive fusional reserve (40cm; PD) 
  Mean SD Median p-value 
Control 
Double point 
3.6 1.1 3.5 
0.56 
PCS 4.1 2.0 4.0 
Control 
Recovery point 
2.4 1.0 2.3 
0.45 
PCS 2.9 1.7 3.0 
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Figure 3-30: Near vertical positive fusional reserve scatter plot 
 
 
3.4.4.5.9 Near vertical negative fusional reserve 
There was no statistically significant difference in the near VNFR between the two groups in 
double (p=0.64) and recovery (p=0.62) points. The SD and median values of both groups also 
appear to be similar, although this was not tested statistically. 
Table 3-24: Near vertical negative fusional reserve (40cm; PD) 
  Mean SD Median p-value 
Control 
Double point 
3.3 1.5 3.1 
0.64 
PCS 4.2 2.8 3.3 
Control 
Recovery point 
2.1 1.0 2.0 
0.62 
PCS 2.9 2.5 2.3 
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Figure 3-31: Near vertical negative fusional reserve scatter plot 
 
 
3.4.4.5.10 Vergence facility 
There was no statistically significant difference in the vergence facility between the two groups 
(p=0.09), although interestingly there was a trend towards vergence facility being worse in the 
PCS group. Visual inspection of the median values also suggests that the control group appears 
to have higher (better) median value than the PCS group. Visual inspection of the SD values 
revealed no obvious differences between groups.  
Table 3-25: Vergence facility (40cm; cpm) 
 Mean SD Median p-value 
Controls 15.8 4.9 16.3 
0.09 
PCS 12.6 5.4 12.2 
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Figure 3-32: Vergence facility scatter plot 
 
 
3.4.5 Global visual function tasks 
3.4.5.1 Visual spatial awareness - cyclopean eye alignment position 
As mentioned in the methods chapter, the technique of measuring the cyclopean eye was 
modified part way through the study. Therefore, there were fewer participants who performed 
the test after the modification was completed (control n=17, PCS n=8). 
There was statistically significant difference in the cyclopean eye position between the two 
groups (p=0.03). And the mean cyclopean eye position of the PCS group was closer to the 
midline (90 degrees) than the control group. This result was supported by observational analysis 
of the median values, which also appeared to be closer to the midline in the PCS group. There 
was no visually observable difference between the SD values of both groups. 
Table 3-26: Visual spatial awareness - cyclopean eye alignment position (50cm; degrees) 
 N Mean SD Median p-value 
Controls 17 81.7 5.2 80.7 
0.03* 
PCS 8 85.7 6.6 88.0 
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There were two outcome measures recorded on the KD test: 1) reading time and 2) number of 
errors made. There was statistically significant difference in the reading time between the two 
groups (p=0.04), and the control group appeared to read faster (took less time to complete the 
task), than the PCS group. There was no statistically significant difference in the number of 
errors made between the two groups. 
Table 3-27: King-Devick (40cm) 
  Mean SD Median p-value 
Controls Reading time 
(seconds) 
48.1 13.7 42.2 
0.04* 




0.3 1.6 0.0 
>0.99 
PCS 0.1 0.3 0.0 
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Figure 3-34: King-Devick (time) scatter plot 
 
 





3.4.6 Visual motor integration 
3.4.6.1 Visual-motor reaction time 
In this test, central and peripheral VMRT were measured. There was a statistically significant 
difference between the two groups in the peripheral VMRT only (p=0.04). Interestingly, the PCS 
group had a better peripheral VMRT compared to the control group. The PCS group also 
appeared to have a better central VMRT as well, although there was no statistical difference in 
central VMRT between groups. Furthermore, visual observation of the SD values suggests that 
the control group appeared to have higher (more variable) SD value in the central and 
peripheral VMRT tasks than the PCS group. The apparent increased variability in the control 
group likely contributed to the lack of a significant difference being found on the central VMRT 
task. 
Table 3-28: Visual-motor reaction time (ms) 
  Mean SD Median p-value 
Control 
Central 
509.1 115.2 492.6 
0.58 
PCS 476.1 74.9 477.3 
Control 
Peripheral 
960.3 236.6 905.7 
0.04* 
PCS 810.0 136.0 812.7 
 




Figure 3-37: Visual-motor reaction time (peripheral) scatter plot 
 
3.4.6.2 Coincidence anticipation timing 
Overall, there were no statistically significant differences between the two groups at any of the 
speeds (5 - 40 mph) tested on any of the outcome measures (constant, absolute, and variable 
errors). Also, visual inspection suggests that there were no specific or consistent trends in the 
mean and SD values amongst the groups.
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Table 3-29: Coincidence anticipation timing (mph) 
 CE AE VE 
 Speed Mean SD Median p-value Mean SD Median p-value Mean SD Median p-value 
Control 
5 
-24.2 31.6 -11.0 
0.23 
47.3 23.1 37.8 
0.52 
42.3 17.4 39.9 
0.66 
PCS -35.6 33.7 -37.5 52.5 25.4 39.5 45.0 20.1 43.2 
Control 
10 
-13.6 26.6 -7.2 
0.27 
34.7 18.7 30.6 
0.64 
32.8 16.9 29.5 
0.22 
PCS -2.6 16.6 -1.7 38.9 20.3 33.5 42.1 20.9 35.95 
Control 
15 
-14.7 26.3 -15.8 
0.96 
47.0 24.3 42.4 
0.83 
49.8 32.1 38.8 
0.85 
PCS -14.9 23.5 -18.8 41.6 11.8 41 44.6 11.3 46.0 
Control 
20 
-9.1 18.1 -10.4 
0.49 
47.1 19.3 46.2 
0.16 
52.2 25.6 49.7 
0.39 
PCS -5.9 26.3 2.7 55.0 16.9 54.6 58.5 21.0 59.6 
Control 
25 
-1.3 21.8 -0.8 
0.18 
40.8 16.6 39.4 
0.09 
45.8 18.5 44.7 
0.12 
PCS -11.2 20.9 -15.7 50.5 12.1 47.4 55.4 13.2 50.7 
Control 
30 
11.9 23.52 13.8 
0.47 
40.0 15.7 36.2 
0.44 
40.2 15.1 38.0 
0.62 
PCS 6.0 19.2 3.6 43.3 15.0 44.5 43.4 18.8 49.4 
Control 
35 
11.6 21.3 11.6 
1.00 
33.1 18.3 28.0 
0.97 
35.0 19.5 30.1 
0.75 
PCS 10.8 22.5 11.0 31.4 13.8 29.0 31.7 14.8 29.2 
Control 
40 
19.0 17.3 14.2 
0.50 
32.3 18.7 29.6 
0.19 
32.1 20.3 30.2 
0.12 





Figure 3-38: Coincidence anticipation timing (CE) scatter plot of the control group 
 
 




Figure 3-40: Coincidence anticipation timing (AE) scatter plot of the control group 
 
 






Figure 3-42: Coincidence anticipation timing (VE) scatter plot of the control group
 
 




 - Results: Symptoms and visual function 
In order to look at the relationship between symptoms and visual functions, Spearman 
correlations were used to compare symptom severity scores and performance on each of the 
visual function tests in each visit for each group. The results of these correlation analyses are 
presented in (Tables 4-1 to 4-26). The significance levels of the correlations between the 
symptom severity and each visual function test are represented by the (p-value) whereas the 
spread of the data is represented by Spearman’s rho (ρ-value) - (Tables 4-1 to 4-26). 
Please note, in all of the tables presented below, p-values marked with a * are significant at 
least p<0.05. On all of the following graphs, grey data represents the control group and black 
data represents the PCS group.  
4.1 Static visual perception 
4.1.1 Static distance visual acuity 
There was no significant correlation between symptom severity and static distance visual acuity 
for either groups. 
Table 4-1: Correlation of symptom severity and static distance visual acuity 
 Control PCS 
 p-value ρ-value p-value ρ-value 
OD 0.45 -0.14 0.57 -0.21 
OS 0.93 -0.02 0.37 -0.32 
OU 0.80 -0.05 0.41 -0.30 
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Figure 4-1: Correlation of symptom severity and static distance visual acuity 
 
 
4.1.2 Static near visual acuity 
There was no significant correlation between the symptom severity and the static near visual 
acuity for both groups. 
Table 4-2: Correlation of symptom severity and static near visual acuity 
 Control PCS 
 p-value ρ-value p-value ρ-value 
OD 0.10 0.29 0.93 -0.03 
OS 0.14 0.26 0.39 -0.31 
OU NA NA 0.12 -0.52 
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Figure 4-2: Correlation of symptom severity and static near visual acuity 
 
 
4.1.3 Contrast sensitivity 
There was no significant correlation between symptom severity and contrast sensitivity for either 
both groups. 
Table 4-3: Correlation of symptom severity and contrast sensitivity 
 Control PCS 
 p-value ρ-value p-value ρ-value 
OU 0.33 0.18 0.93 -0.03 
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Figure 4-3: Correlation of symptom severity and contrast sensitivity 
 
 
4.2 Dynamic visual perception 
4.2.1 Dynamic distance visual acuity 
There was no significant correlation between symptom severity and dynamic visual acuity for 
both groups. 
Table 4-4: Correlation of symptom severity and dynamic distance visual acuity 
 Control PCS 
 p-value ρ-value p-value ρ-value 
Horizontal 0.54 -0.12 0.75 0.46 
Random 0.29 -0.20 0.59 0.21 
Jitter 0.86 0.03 0.18 0.12 
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Figure 4-4: Correlation of symptom severity and dynamic visual acuity 
 
 
4.3 Refractive status 
4.3.1 Objective refraction 
There was no significant correlation between symptom severity and refractive error for both 
groups. 
Table 4-5: Correlation of symptom severity and objective refraction (spherical equivalent) 
 Control PCS 
 p-value ρ-value p-value ρ-value 
OD 0.67 0.08 0.20 -0.44 
OS 0.74 0.06 0.20 -0.45 
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Figure 4-5: Correlation of symptom severity and objective refraction (spherical equivalent) 
 
 
4.4 Binocular vision 
4.4.1 Ocular alignment 
4.4.1.1 Distance ocular alignment 
There was no significant correlation between symptom severity and distance ocular alignment 
for either group. 
Table 4-6: Correlation of symptom severity and distance ocular alignment 
 Control PCS 
 p-value ρ-value p-value ρ-value 
Primary gaze 0.17 -0.25 0.48 0.26 
Left gaze 0.33 -0.18 0.48 0.26 
Right gaze 0.45 -0.14 0.20 0.44 
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Figure 4-6: Correlation of symptom severity and distance ocular alignment 
 
 
4.4.1.2 Near ocular alignment 
There was no significant correlation between symptom severity and near ocular alignment for 
either group. 
Table 4-7: Correlation of symptom severity and near ocular alignment 
 Control PCS 
 p-value ρ-value p-value ρ-value 
Primary gaze 0.74 -0.06 0.39 0.31 
Left gaze 0.99 0.00 0.39 0.31 











There was a significant negative correlation between symptom severity and stereopsis for the 
control group and an increase in symptom severity was found to be associated with less (better) 
stereopsis. Even though this correlation was significant, stereopsis measures could only 
account for or be explained by 41% of the symptom severity score.   
No significant correlation between symptom severity and stereopsis was found for the PCS 
group. 
Table 4-8: Correlation of symptom severity and stereopsis 
 Control PCS 
 p-value ρ-value p-value ρ-value 
Stereopsis 0.02* -0.41 0.67 0.15 
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Figure 4-8: Correlation of symptom severity and stereopsis 
 
 
4.4.3 Accommodation function 
4.4.3.1 Amplitude of accommodation 
There was no significant correlation between symptom severity and the amplitude of 
accommodation for both groups. 
Table 4-9: Correlation of symptom severity and amplitude of accommodation 
 Control PCS 
 p-value ρ-value p-value ρ-value 
OD 0.46 -0.13 0.41 -0.29 
OS 0.37 -0.16 0.41 -0.30 
Absolute difference 0.45 -0.14 0.27 0.39 
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Figure 4-9: Correlation of symptom severity and amplitude of accommodation 
 
 
4.4.3.2 Accommodation accuracy 
There was no significant correlation between symptom severity and the accommodation 
accuracy for both groups. 
Table 4-10: Correlation of symptom severity and accommodation accuracy 
 Control PCS 
 p-value ρ-value p-value ρ-value 
OD 0.32 -0.18 0.47 -0.26 
OS 0.42 -0.15 0.82 -0.08 
Absolute difference 0.52 0.12 0.44 -0.28 
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Figure 4-10: Correlation of symptom severity and accommodation accuracy
 
 
4.4.3.3 Accommodation facility 
There was no significant correlation between symptom severity and the accommodation facility 
for both groups. 
Table 4-11: Correlation of symptom severity and accommodation facility 
 Control PCS 
 p-value ρ-value p-value ρ-value 
OD 0.17 0.25 0.93 0.03 
OS 0.44 0.14 0.85 0.07 
Absolute difference 0.69 0.07 0.48 -0.25 
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Figure 4-11: Correlation of symptom severity and accommodation facility 
 
 
4.4.3.4 Negative and positive relative accommodation 
There were no significant correlations between symptom severity and the negative and positive 
relative accommodation measures for both groups. 
Table 4-12: Correlation of symptom severity and NRA and PRA 
 Control PCS 
 p-value ρ-value p-value ρ-value 
NRA 0.31 -0.36 0.06 0.68 
PRA 0.32 0.35 0.97 0.02 
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Figure 4-12: Correlation of symptom severity and negative relative accommodation 
 





4.4.4 Vergence function 
4.4.4.1 Near point of convergence 
There was no significant correlation between symptom severity and the near point of 
convergence for both groups. 
Table 4-13: Correlation of symptom severity and near point of convergence 
 Control PCS 
 p-value ρ-value p-value ρ-value 
Break point 0.88 -0.03 0.61 0.18 
Recovery point 0.47 -0.13 0.78 0.10 
Difference 0.16 -0.25 0.89 0.05 
 
Figure 4-14: Correlation of symptom severity and near point of convergence 
 
 
4.4.4.2 Distance horizontal positive fusional reserve 
There were no significant correlations between symptom severity and the distance horizontal 
positive fusional reserve measures for either group. 
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Table 4-14: Correlation of symptom severity and distance HPFR 
 Control PCS 
 p-value ρ-value p-value ρ-value 
Blur point 0.89 0.03 0.19 -0.45 
Double point 0.91 0.02 0.75 -0.11 
Recovery point 0.64 0.08 0.66 -0.16 
 
Figure 4-15: Correlation of symptom severity and distance HPFR 
 
 
4.4.4.3 Distance horizontal negative fusional reserve 
Except from the blur point in the control group, there were no significant correlations between 
symptom severity and the distance horizontal negative fusional reserve for both groups. The 
blur point in the control group demonstrated a significant negative correlation with symptom 
severity, whereby an increase in symptom severity was associated with a lower (worse) blur 
point value. Even though this correlation was significant, the blur point measure could only 
account for or be explained by 36% of the symptom severity score. 
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Table 4-15: Correlation of symptom severity and distance HNFR 
 Control PCS 
 p-value ρ-value p-value ρ-value 
Blur point 0.04* -0.36 0.25 -0.40 
Double point 0.55 -0.11 0.99 -0.003 
Recovery point -0.29 -0.19 0.99 -0.003 
 
Figure 4-16: Correlation of symptom severity and distance HNFR 
 
 
4.4.4.4 Distance vertical positive fusional reserve 
There were no significant correlations between symptom severity and the distance vertical 
positive fusional reserve measures for either group. 
Table 4-16: Correlation of symptom severity and distance VPFR 
 Control PCS 
 p-value ρ-value p-value ρ-value 
Double point 0.10 -0.29 0.51 -0.24 
Recovery point 0.37 -0.16 0.51 -0.24 
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Figure 4-17: Correlation of symptom severity and distance VPFR
 
 
4.4.4.5 Distance vertical negative fusional reserve 
There were significant negative correlations between symptom severity and the distance vertical 
negative fusional reserve double point and recovery point measures in the control group. As 
symptom severity increased, the distance vertical negative fusional reserve double point and 
recovery point values decreased indicating poorer distance VNFR. There was no significant 
correlation between symptom severity and the distance vertical negative fusional reserve 
measures in the PCS group. 
Even though the double and recovery point correlations were significant in the control group, the 
double and recovery points could only account for or be explained by 45% and 39% of the 
symptom severity score, respectively. 
Table 4-17: Correlation of symptom severity and distance VNFR 
 Control PCS 
 p-value ρ-value p-value ρ-value 
Double point 0.01* -0.45 0.90 -0.05 
Recovery point 0.02* -0.39 0.90 -0.05 
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Figure 4-18: Correlation of symptom severity and distance VNFR 
 
 
4.4.4.6 Near horizontal positive fusional reserve 
There were no significant correlations between symptom severity and the near horizontal 
positive fusional reserve measures for either group. 
Table 4-18: Correlation of symptom severity and near HPFR 
 Control PCS 
 p-value ρ-value p-value ρ-value 
Blur point 0.51 0.12 0.41 -0.29 
Double point 0.92 -0.02 0.17 -0.47 
Recovery point 0.99 -0.001 0.17 -0.47 
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Figure 4-19: Correlation of symptom severity and near HPFR 
 
 
4.4.4.7 Near horizontal negative fusional reserve 
There were no significant correlations between symptom severity and the near horizontal 
negative fusional reserve measures for either group. 
Table 4-19: Correlation of symptom severity and near HNFR 
 Control PCS 
 p-value ρ-value p-value ρ-value 
Blur point 0.53 -0.11 0.50 0.24 
Double point 0.92 -0.02 0.71 0.14 
Recovery point 0.84 -0.04 0.97 -0.02 
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Figure 4-20: Correlation of symptom severity and near HNFR 
 
 
4.4.4.8 Near vertical positive fusional reserve 
There were no significant correlations between symptom severity and the near vertical positive 
fusional reserve measures for either group. 
Table 4-20: Correlation of symptom severity and near VPFR 
 Control PCS 
 p-value ρ-value p-value ρ-value 
Double point 0.32 -0.18 0.87 0.06 
Recovery point 0.49 -0.12 0.86 0.07 
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Figure 4-21: Correlation of symptom severity and near VPFR 
 
 
4.4.4.9 Near vertical negative fusional reserve 
There were no significant correlations between symptom severity and the near vertical negative 
fusional reserve measures for either group. 
Table 4-21: Correlation of symptom severity and near VNFR 
 Control PCS 
 p-value ρ-value p-value ρ-value 
Double point 0.09 -0.10 0.99 -0.006 
Recovery point 0.07 -0.32 0.83 -0.08 
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Figure 4-22: Correlation of symptom severity and near VNFR 
 
 
4.4.4.10 Vergence facility 
There was no significant correlation between symptom severity and vergence facility for both 
groups. 
Table 4-22: Correlation of symptom severity and vergence facility 
 Control PCS 
 p-value ρ-value p-value ρ-value 
Vergence facility 0.90 -0.02 0.63 0.18 
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Figure 4-23: Correlation of symptom severity and vergence facility 
 
 
4.5 Global visual function tasks 
4.5.1 Visual spatial awareness - cyclopean eye alignment position 
There was no significant correlation between symptom severity and the cyclopean eye position 
result for both groups. 
Table 4-23: Correlation of symptom severity and cyclopean eye alignment position 
 Control PCS 
 p-value ρ-value p-value ρ-value 
Cyclopean eye alignment 0.68 -0.11 0.77 0.13 
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There were no significant correlations between the symptom severity and either the KD time or 
KD errors results for either group. 
Table 4-24: Correlation of symptom severity and King-Devick 
 Control PCS 
 p-value ρ-value p-value ρ-value 
Time 0.53 0.11 0.48 -0.25 
Errors 0.14 -0.26 0.75 0.12 
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Figure 4-25: Correlation of symptom severity and King-Devick 
 
 
4.6 Visual motor integration 
4.6.1 Visual-motor reaction time 
There were no significant correlations between symptom severity and visual-motor reaction 
times (central and peripheral) for both groups.  
Table 4-25: Correlation of symptom severity and visual-motor reaction time 
 Control PCS 
 p-value ρ-value p-value ρ-value 
Central 0.20 -0.23 0.19 -0.24 
Peripheral 0.80 0.09 0.35 0.33 
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Figure 4-26: Correlation of symptom severity and central visual-motor reaction time 
 
 





4.6.2 Coincidence anticipation timing 
For the most part there were no significant correlations between symptom severity and the 
coincidence anticipation timing measures for both groups except the following outcome 
measures, which were significant correlated in the PCS group only: 
1) Constant error - speed 35 (mph): a significant negative correlation was present. This 
indicates that PCS participants with more severe symptoms tended to have later 
responses to the stimulus at this particular speed.  
2) Variable error - speed 35 (mph): a significant negative correlation was present. This 
indicates that PCS participants with more severe symptoms tended to have more 
variable, inconsistent responses at this stimulus speed. 
3) Absolute error - speed 10 (mph): a significant positive correlation was present. This 
indicates that PCS participants with more severe symptoms tended to have higher 
absolute error values (or were more inaccurate overall) when responding to the 
stimulus at this stimulus speed. 
One possible explanation for the poorer performance in the PCS participants with more 
symptoms is that these participant’s symptoms were associated with slower reaction times and / 
or difficulty attending to the task. An alternative explanation, at least for the poorer performance 
at 35 mph in the PCS group was that this task was just more challenging than some of the other 




Table 4-26: Correlation of symptom severity and coincidence anticipation timing 
 Control PCS 
Speed p-value ρ-value p-value ρ-value 
Constant error 
5 0.670 -0.077 0.738 -0.122 
10 0.186 0.236 0.763 -0.109 
15 0.431 -0.142 0.532 0.225 
20 0.384 -0.157 0.521 0.231 
25 0.997 0.001 0.868 -0.061 
30 0.086 -0.304 0.614 0.182 
35 0.876 -0.028 0.04* -0.663 
40 0.541 -0.110 0.947 -0.024 
Variable error 
5 0.501 -0.121 0.947 -0.024 
10 0.173 -0.243 0.336 0.340 
15 0.486 0.126 0.751 -0.116 
20 0.822 0.041 0.763 0.109 
25 0.433 0.141 0.250 -0.401 
30 0.833 0.038 0.663 -0.158 
35 0.277 0.195 0.01* -0.742 
40 0.538 -0.111 0.614 -0.182 
Absolute error 
5 0.097 0.294 0.934 -0.030 
10 0.223 -0.218 0.04* 0.644 
15 0.819 0.041 0.960 -0.018 
20 0.523 0.115 0.555 -0.213 
25 0.470 0.130 0.521 0.231 
30 0.555 0.107 0.763 -0.109 
35 0.091 0.299 0.166 -0.474 
40 0.610 -0.092 0.861 -0.064 
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Figure 4-28: Correlation of symptom severity and coincidence anticipation timing - 5 mph 
 
 





Figure 4-30: Correlation of symptom severity and coincidence anticipation timing - 15 mph 
 
 





Figure 4-32: Correlation of symptom severity and coincidence anticipation timing - 25 mph 
 
 





Figure 4-34: Correlation of symptom severity and coincidence anticipation timing - 35 mph 
 
 





4.7 Other observations: symptoms and examination length 
As mentioned in the methods chapter, the length of the study visits was about 1 hour and 20 
minutes for visit 1 and 45 to 60 minutes for visit 2. However, some of the PCS participants 
experienced symptom exacerbation during the assessments and required breaks, which 
prolonged the length of the visits. None of the control participants experienced symptom 
exacerbation during the study visit. 
It is worth mentioning that a break from testing was given whenever the participant asked for 
one, and testing only continued when the participant was ready. Although the study protocol 
was not designed to look at test breaks or symptoms exacerbation during testing, the examiner 
thought it was an important behavioral difference between the groups and should be recorded, 
especially as this study was exploratory in nature. Therefore, the study examiner recorded the 
breaks given along with the participant’s reported symptoms every time a break was given. 
Unfortunately, neither the length of the break nor the overall length of the study visit was 
recorded. 
The process of recording test breaks and symptoms started with the second PCS participant 
who took part in the study. This participant also happened to be the first participant who 
experienced symptom exacerbation and the first participant to ask for a break. There were only 
two PCS participants who did not experience symptom exacerbation during testing. On the 
other hand, there were eight PCS participants who did experience symptom exacerbation. Of 
the eight PCS participants who experienced symptom exacerbation, only one participant 
reported light sensitivity but never asked for a break (Participant 10). All of the other PCS 
participants who reported symptom exacerbation asked for breaks. It is important to mention 
that Participant 10 wore tinted non-prescription glasses between tests, but not during the tests. 
Table 4-27 highlights the symptoms reported by each PCS participant and the visual function 
tests associated with symptom exacerbation. If symptoms were recorded, then a break was 




Overall, only nine tests of the tests conducted in this study seemed to provoke symptoms in the 
PCS group. These tests are as follows: near ocular alignment, ocular motility, amplitude of 
accommodation, near point of convergence, accommodation facility, vergence facility, dynamic 
visual acuity, distance horizontal positive fusional reserve, and visual-motor reaction time. 
Near point of convergence and accommodation facility tests appeared to be the most 
provocative, because these two tests triggered symptoms that caused the highest number of 
participant breaks. On the contrary, the near ocular alignment and the distance horizontal 
positive fusional reserve tests triggered the lowest number of participant breaks (Table 4-27). 
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 - Discussion 
The objectives of the current study were as follows: 1) to apply a comprehensive visual function 
test battery in both control and PCS individuals 2) to compare performance on the 
comprehensive visual function test battery between control and PCS individuals 3) to determine 
if performance on the comprehensive visual function test battery was in any way related to the 
symptoms individuals with PCS experience. In this chapter, the discussion will be structured 
around the study objectives to determine if the study was able to fulfill its objectives. 
5.1 Establishment of the visual function test battery 
A comprehensive visual function test battery was applied in this study. The test battery 
consisted a number of assessments that were completed across two study visits. The 
assessments completed included health history questionnaires, static visual perception tests, 
dynamic visual function tests, binocular vision tests, global visual function tests, and visuomotor 
integration tests. The tests conducted in each visit were listed in Table 2-1. 
The test battery appears to be feasible in both the control and PCS groups, and all of the 
participants successfully completed all of the tests in the battery and the two study visits. It is 
interesting to note that a number of the PCS participants took longer to complete the study visits 
than the control participants, because some of the tests in the battery caused an increase in 
participant symptoms that required breaks to be taken during the exam. This finding is 
interesting in its own right, and will be discussed in more detail below.  
It is important to mention there was one PCS participant who was excluded from the study. 
When this participant contacted the study examiner, the participant was eligible to participate in 
this study and was an excellent candidate for the PCS group (see 2.2.2 Inclusion/Exclusion 
criteria of the PCS group). The only time that worked for the participant to join the study was 
about a month after contacting the study examiner at which time, the participant successfully 
joined the study and completed the study visits. At the time of data entry, the study examiner 
realized that this participant reported only one symptom on the day of testing and.no longer met 




5.2 Comparing performance on the comprehensive visual function test battery between 
control and PCS groups 
5.2.1 Static visual perception 
5.2.1.1 Static distance visual acuity 
In this study, the mean and median values of static distance VA of both groups fall within the 
established normal range39,42 and were not different between groups. Testing static distance 
visual acuity did not provoke any participant symptoms either. These findings suggest that static 
distance visual acuity is less likely to be affected in individuals with concussion or PCS, and that 
this test has less utility for providing an objective measure of concussion and PCS recovery. 
5.2.1.2 Static near visual acuity 
There was no difference in the static near VA between the groups in OD, OS, or OU. Mean and 
median values for both groups were (0.40 M) which is the smallest print on the chart. This 
finding indicates excellent static near VA among groups. However, the PCS group as a whole 
was less consistent on this test than the control group. Examination of the scatter plot for static 
near VA, reveals that the observed inconsistency in the PCS group was caused by an outlier. 
Upon further examination of this particular PCS participant, there did not appear to be a major 
refractive error issue that caused this reduction in near VA (OD: 0.12-0.12x104 - OS: 0.25-
0.25x38). However, this participant was the only participant that reported experiencing a loss of 
consciousness for >1 minute at the time of their concussion incident. It is well-known that 
concussion is rarely accompanied with loss of consciousness.1,3,10,69 Loss of consciousness has 
not been proven to be a risk factor for significant deficits post-concussion,3,70 but it was the only 
compelling factor for the observed decrease in near VA for this case. This case highlights the 
importance of studying the PCS population as individual cases3 to look at other potential 
confounding factors that may explain specific deficits and/or behaviours.   
5.2.1.3 Contrast sensitivity 
In this study, contrast sensitivity was found to be similar between groups, and consistent with 
the established CS normal values for this age group.39,47 Like static visual acuity, it appears that 
CS did not differentiate between healthy controls and PCS participants in this study. Previous 
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research has shown that contrast sensitivity is reduced in individuals following TBI, so the 
findings of this study may suggest that the test used was not sensitive enough to detect 
differences in CS between groups.71,72 The study findings could also suggest that the population 
sample studied was not either large enough to detect differences in CS, or that the injury 
population in particular did not have severe enough injuries to affect their contrast sensitivity 
values. An alternative explanation is that most of the PCS group was high-level athletes, while 
most of the control group were recreational or non-athletes. It is possible that CS was reduced 
in the high-level athletes with PCS compared to other high-level athletes, but not reduced 
compared to the controls. While it was not possible to examine this last explanation within the 
current study sample, it is important to consider matching the athletic background of participants 
in future studies.  
5.2.2 Dynamic visual perception 
5.2.2.1 Dynamic visual acuity 
DVA was similar between the two groups in horizontal, jitter, and random motions. It is important 
to mention that DVA for the jitter motion of both groups appeared to be better than for the 
random and horizontal motions. This could be due to the fact that during the jitter movement, 
participants were required to make fewer eye movements to find the target than during the 
horizontal and random motion tasks. This was because the target in the jitter motion task stayed 
at the centre of the screen; therefore, the image fell on the foveal area with minimal effort, and 
likely made it easier to recognise. This finding is similar to the results found in the validation 
study of the same DVA test (moV&).48 The population samples studied here, DVA tests did not 
appear to be effective measures for distinguishing visual function deficits in normal and PCS 
individuals. DVA has been shown to be better in healthy dynamic sport athletes than controls73; 
therefore, it is possible that the athletic background of the PCS participants may have masked 
any deficits in performance when comparing this group to the control group of mainly 
recreational athletes and non-athletes.  
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5.2.3 Refractive status 
5.2.3.1 Objective refraction 
Spherical equivalent refractive errors were found to be similar between groups, and objective, 
non-cycloplegic refraction does not appear to be a strong measure for identifying visual 
dysfunction associated with PCS. It is important to mention that 18 control participants (55%) 
and 4 PCS participants (40%) wore prescription glasses or contact lenses on the days of 
testing. The remainder of the participants did not have refractive corrections. 
5.2.4 Binocular vision 
5.2.4.1 Ocular Alignment  
5.2.4.1.1 Distance ocular alignment 
The distance ocular alignment test was similar between the groups in the primary, left, and right 
gazes, and the distance ocular alignment of both groups appeared to be similar to the 
established normal values of distance phoria.50,74 Additionally, there was no incomitancy (≥5 PD 
difference in the ocular misalignment between gazes75) found between the primary, left, and 
right gazes among participants in both groups. Therefore, in this study, the distance ocular 
alignment test had less utility in distinguishing visual dysfunctions in the PCS group as a whole. 
5.2.4.1.2 Near ocular alignment  
The near ocular alignment test was also similar between the groups in the primary, left, and 
right gazes and no incomitant deviations were noted. Near ocular alignment was similar to the 
established normal values of near phoria in both groups,50 however, the normative values used 
for comparison were reported in children, which is a different population than the population of 
this study.  
Although not significantly different from the controls, the PCS group appeared to have slightly 
more near exophoria at near than the control group. Additionally, the mean and median values 
of the PCS group suggested that the PCS group had higher exophorias at near compared to 
distance, which can be an indicator of convergence insufficiency.26,76,77 This finding suggests 
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that the near ocular alignment test has the potential to distinguish lingering visual dysfunctions 
in PCS individuals. Hence, it is worth including this test in visual function assessments of 
individuals with PCS. 
5.2.4.2 Ocular motility  
There were no abnormalities found in the control group participants in terms of eye movements. 
Conversely, irregular eye movements were found in three participants of the PCS group. The 
irregular eye movements in the PCS participants were accompanied with symptoms of irritation, 
and aching behind the eyes. 
The abnormal, irregular eye movements could be due to impaired nervous innervation of the 
eye muscles or due to deficits in the eye muscles themselves.50 Additionally, these 
abnormalities could be attributed to higher order processing deficits of the brain stem.50 It is 
unclear whether or not the abnormalities observed in this study were caused by a pre-existing 
structural abnormality in the nerves or the eye muscles that manifested after the concussion 
incident,78 or if they were new abnormalities that had just developed. In 2010, a study was 
conducted to investigate the presence of cranial nerve injuries after mTBI, and determined that 
cranial nerve injuries occurred in number of the cranial nerves including the oculomotor nerve 
(III), trochlear nerve (IV), and abducens nerve (VI), which are the main nerves that control eye 
movements. As part of this 2010 study, a follow-up assessment was conducted one year after 
the initial assessment, and 3 out of 10 cases demonstrated persistent cranial nerve deficits that 
were present despite no associated abnormalities being found on the CT scan.79 The findings of 
this study suggest that functional abnormalities of the cranial nerves can exist in the absence of 
any obvious structural abnormalities as detected by current conventional neuroimaging 
techniques. This argument is supported by another study that determined eye movement 
impairments were present in a PCS sample who did not have any obvious structural 
neurological deficits.80 
It is well-known that eye movements determine the visual information received by the retina and 
processed by the visual cortex. Therefore, eye movements are an important part of visually 
guided functions such as balance.81 Determining that eye movement deficits exist in PCS 
individuals with the Broad H, which is considered an eye movement screening test, 
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demonstrates that it is important to study eye movement functions in PCS in more sophisticated 
way. In studying eye movements more precisely, it would be important to determine if deficits in 
eye movements correlate with deficits in balance. This would be an interesting study to 
complete because it would build on previous research which has shown that deficits of 
balance,81 the vestibulo-ocular reflex,22 and visual-motor coordination24 exist in the PCS 
population.  
5.2.4.3 Stereopsis 
Stereopsis was similar between the groups, and the findings in both groups were consistent with 
the normal stereopsis values in a similar age group.82 In this particular study, stereopsis did not 
differentiate between the control and PCS groups, suggesting that stereopsis might not be an 
effective objective measure of visual dysfunction in PCS. However, stereopsis is an excellent 
tool to rapidly assess global binocular vision at near, and so may still have some clinical utility in 
the PCS population.  
5.2.4.4 Accommodation function 
5.2.4.4.1 Amplitude of accommodation 
In this study, AA was measured following Hofstetter’s formula for the minimum age expected 
AA. If the total was positive that indicates the participant had a better AA than average and vice 
versa. The majority of participants in this study had better than average AA for OD, OS, and the 
absolute difference between the two eyes, and there was no difference in AA between groups 
on any of the parameters measured. The results of the AA tests suggest that AA may be less 
able to differentiate PCS individuals with visual dysfunction from normal, non-concussed 
individuals.   
5.2.4.4.2 Accommodation accuracy 
Accommodation accuracy was similar between the two groups for OD, OS, and the absolute 
difference between the two eyes. There is lack of normative data on the accommodation 
accuracy data. However, there was one study conducted by Ma et al. (1999) that examined 
accommodation accuracy with the MEM technique in participants of similar age to the current 
study participants. Ma et al.’s study examined the OD only (neither the OS nor the absolute 
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difference between the eyes was examined), however, the OD accommodation accuracy found 
in the current study were similar to the OD accommodation accuracy found by Ma et al. 
(1999).83 
Although there was no statistically significant difference found between groups in this test, there 
were unusual behaviours in the accommodation of three participants from the PCS group. 
These participants had a lag of accommodation in one eye and a lead of accommodation in the 
other eye. To our knowledge, this imbalance in the accommodation behaviour has not been 
reported in any other study.  
Participants were examined with their habitual correction, if they had one, and it is possible that 
the retinoscopy reflex seen was an overcorrection and/or under-correction of the participant’s 
own refractive correction.50 Also, it is possible that the retinoscopy reflex seen was an 
uncorrected refractive error.50 The table below presents information on the refractive error and 
the accommodation accuracy findings for these three PCS participants (Table 5-1). With that 
being said, improper correction of participant’s own refractive error is less likely to be the cause 
of this unusual finding because this finding was not found in the control group as well. Moreover, 
these three participants had excellent near VA (0.40M) in OD, OS, and OU. For participant 1 
and 3 particularly, it is even more unlikely that what was seen in the retinoscopy was refractive 
errors. Although these participants had lead of accommodation in the OD, they had no minus 
spherical refractive error in the same eye. Furthermore, they had an astigmatic refractive error 
on the horizontal axis (opposite to the axis of the retinoscopy streak, which was vertical). For 
these reasons, it is less likely that these abnormal findings were due to refractive errors. 
Therefore, because this abnormal finding was not found in the control group and it is not 
commonly seen in healthy populations, it could be a visual dysfunction that resulted specifically 
from these participant’s concussions. It is possible the initial concussion injury resulted in an 
insult to the corresponding visual pathway responsible for accommodation, which includes the 
oculomotor nerve (III), and resulted in the deficits observed in this study.  
However, the question becomes why this abnormality occurred in only a few participants. That 
could be attributed to different reasons such as injury mechanism and/or medication side-effects 
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which are beyond the scope of this thesis. It could also have been associated with the number 
of previous concussions participants had or the time since their injury, although neither of these 
relationships were explored in this thesis either. These results do suggest that the 
accommodation accuracy test appears to be a valuable objective measure in the assessment of 
visual dysfunction in PCS. In addition, these findings again highlight the importance of studying 
the PCS participants as separate cases and investigating the potential contributing factors to 
each presented abnormality, rather than studying them as a homogenous group.  





























5.2.4.4.3 Accommodation facility 
The mean monocular AF values of both groups were consistent with established AF mean 
values in the literature,50,84 and were similar between groups. Therefore, AF does not appear to 
demonstrate utility in differentiating individuals with PCS visual dysfunction from controls.  
5.2.4.4.4 Negative and positive relative accommodation 
NRA and PRA were similar between the two groups and consistent with established values in 
the literature.50 Therefore NRA and PRA appear to have less potential to differentiate visual 
dysfunction in PCS from normal visual function in controls, especially when compared to other 
test such as accommodation accuracy and oculomotor control. 
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5.2.4.5 Vergence function 
5.2.4.5.1 Near point of convergence 
In this study, the mean NPC break and recovery point values for both groups were similar to the 
established norms in the literature,39,50,56,57 and were not different between groups. In the current 
study, the NPC test does not seem to be a strong objective measure for visual dysfunctions in 
PCS, however the findings of this study are inconsistent with previous literature in the TBI and 
PCS populations, which has found that reduced NPC and convergence insufficiency are very 
commonly associated with visual dysfunction following concussion.28,31,78,85 The small sample 
size of our PCS group may be one of the reasons behind the lack of significant difference in 
NPC values between groups. Another possibility is that many of the controls were tested during 
the university exam period, and may have had some mild visual dysfunction as a result of 
fatigue from studying, however the NPC values in both groups were normal so this may be less 
likely.   
5.2.4.5.2 Distance horizontal positive and negative fusional reserve 
Distance HPFR results were similar between groups, and both groups had higher (better) 
values for the blur point which resulted in higher (better) values for the break and recovery 
points; values for all three points were all slightly higher (better) than clinically accepted 
norms.39,50  
For the distance HNFR test, both groups had similar break and recovery values, and these 
values were within the clinical accepted norms for this test.50,75  
These findings suggest that both distance horizontal fusional reserve tests may have less 
potential to make a distinction between control and PCS participants. 
5.2.4.5.3 Distance vertical positive and negative fusional reserve 
It is important to mention that there is no established normative data on vertical fusional 
reserves in general. However, it is known that vertical FR values are usually less than horizontal 
FR values75, which is consistent with the findings in this study. In this study, the distance vertical 
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fusional reserve tests were not different between groups and do not appear to be capable of 
differentiating controls from PCS participants.    
5.2.4.5.4 Near horizontal positive and negative fusional reserve 
In this study, the near HPFR and HNFR the mean and median values of both groups were 
similar and were within the clinical accepted norms.50  
However, the PCS group appeared to demonstrate more variability on the near HPFR test than 
the controls (Figure 3-28). This variability again suggests that the PCS cases be considered 
individually in order to look for potential confounding factors that generated the variability. For 
instance, recurrent concussions have been a proposed as a factor associated with slower 
recovery, longer lasting PCS symptoms, and other clinically significant conditions such as 
depression.86–88 By looking at the test data closely, it appears that the PCS participant with the 
highest number of concussions (11 sustained concussions) had the lowest near HPFR values 
among PCS participants. Conversely, another PCS participant with only one sustained 
concussion had the highest values in this test. The wide variety in the number of previous 
concussions within the PCS population studied (range 1 – 11, median 2.5; see Table 3-3) may 
be a possible explanation for the high variability within the PCS group in this study. 
With that being said, it is difficult to draw this conclusion based on observations from two PCS 
participants. However, these are still interesting observations that should be further studied to 
better understand the effect of recurrent concussions on visual function performance. 
Furthermore, this preliminary finding strongly suggests that PCS individuals are different and 
they should be studied individually rather than a whole group, and that the near horizontal 
fusional reserve tests have strong potential to uncover visual dysfunctions associated with PCS. 
5.2.4.5.5 Near vertical positive and negative fusional reserve 
The near VPFR and VNFR were similar between the two groups. Similar to the comment made 
on the distance VPFR and VNFR tests, there is no established norms to look at in parallel to the 
results in this study, but the near vertical FR values found in this study were less than the near 
horizontal FR values as expected.75 Similar to the distance vertical fusional reserve tests, near 
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vertical fusional reserve tests do not appear to be capable of differentiating controls from PCS 
participants.    
5.2.4.5.6 Vergence facility 
Although there was no significant difference in VF between the two groups, the control group 
appeared to have better mean and median values than the PCS group, but not to an extent that 
made a significant difference.  
VF depends on rapid change in vergence, which is a type of bilateral eye movement that 
typically occurs when both eyes turn nasally or both eyes turn temporally. The results of this 
study suggest that vergence facility might have been slightly affected in the PCS group, but it 
was not affected as much as other eye movement tests (i.e. Broad H) and the King-Devick test 
(global reading ability that utilises eye movements) that were significantly worse in the PCS 
group. Furthermore, this finding suggests that the VF test is worth considering in the 
assessment of visual function in individuals with PCS. 
5.2.5 Global visual function  
5.2.5.1 Visual spatial awareness - cyclopean eye alignment position 
Interestingly, on this test, the PCS group exhibited significantly less visual direction shift 
(performed better) than the control group. As mentioned earlier, about half of the control 
participants were involved in different recreational sport activities whereas most of the PCS 
participants practiced sports at a higher level. It has been determined that experienced athletes 
often provide more precise feedback on visual-spatial awareness tasks compared to the non-
athletes,89,90 therefore it is possible that the PCS group’s athletic background level enhanced 
their visual function in this test to the extent that their performance surpassed the control group. 
Once again, this test results highlights the importance of comparing healthy athletes with PCS 
athletes in future studies in order to understand how athletic background affects test outcomes. 
5.2.6 King-Devick  
On the KD test, the control group performed significantly better and had a shorter (faster) 
reading time than the PCS group by about 18 seconds. Although KD is a simple reading task, it 
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captures underlying brain deficits that correlate with functions such as saccadic eye 
movements.34,62 Research studies have determined that the KD test is a useful tool for 
concussion screening and as a sideline concussion assessment in sports.34,62 The finding of the 
current study, that reading time is faster in the control group is similar to other studies that 
compared KD test results between control and PCS groups and found that reading time in PCS 
groups was longer than in controls.91,92 It is suggested that the longer reading time in the PCS 
population may indicate the presence of some underlying subcortical brain damage that affects 
eye movements.91,92 In this study, KD reading time appeared to be a strong objective measure 
of visual dysfunction in the PCS group, and the  KD test should be included in the assessment 
of visual function in PCS individuals.   
Despite the longer reading time in the PCS group, there was no difference in the KD number of 
sustained error results between the two groups in this study, which suggests that aspects of the 
KD task involved in processing visual information accurately were functioning equally in both 
groups.  
5.2.7 Visual-motor integration 
5.2.7.1 Visual-motor reaction time 
Peripheral VMRT is usually higher (slower) than central VMRT because the peripheral VMRT 
targets are further apart than the central targets. The peripheral VMRT targets are further apart 
because they need to be separated by a larger visual angle than the central targets, and this 
means they take more time to be hit.93,94 The results of the current study are consistent with this 
previous literature, and in both groups, the peripheral VMRT was higher than the central one.  
Although there was no statistical difference between the two groups in the central VMRT, the 
PCS group had a faster central VMRT than the control group. Additionally, peripheral VMRT in 
the PCS group was significantly faster than in the control group. These differences in VMRT are 
likely a result of the differences in sports activity between the two groups. As mentioned earlier, 
about half of the control participants were involved in different recreational sport activities 
whereas most of the PCS participants practiced sports on a higher level of competition. Some 
studies suggest that athletes have superior VMRT compared to non-athletes.95,96 Therefore, the 
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observed difference in peripheral VMRT might be related to participants athletic backgrounds. If 
so, it might be possible that the PCS group had peripheral VMRT deficits compared to healthy 
athletes, even though the PCS group was still better than the controls. In future studies it would 
be good to compare athletes with PCS to healthy athletes without PCS, as this would inform 
whether or not athletic background should be accounted for in future studies.   
5.2.7.2 Coincidence anticipation timing 
The CAT test did not differentiate healthy controls from PCS individuals. This finding suggests 
that the CAT test may has less potential to assess visual dysfunctions associated with PCS. It is 
important to mention that there is no established normative data on the CAT test in the 
literature. The data available in the literature varies based on the population, stimulus speed, 
and the testing method,63,67,68,97,98 which makes it impossible to compare the literature with the 
results of the current study. 
5.3 Correlation of symptom severity and visual function 
A correlation statistical analysis was conducted to gain an insight into whether or not 
performance on the visual function tests correlated with symptom severity in each group and to 
understand if these correlations were different between the two groups in any way. This 
understanding could help in explaining the visual function performance in relation to the 
symptoms in the PCS group specifically. 
5.3.1 Correlation of symptom severity and visual function in the control group 
As mentioned in the introduction chapter, PCS symptoms have been found in individuals with no 
history of head injuries.14 In this study, the control population was also found to have some PCS 
symptoms despite not having a history of head injury. Hence, it would not be surprising to find 
some correlations between symptoms and visual functions in the control group. 
 For the control group, significant correlations between symptom severity and most of the visual 
function tests were not found. Significant correlations were only found for the following tests: 
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1) a negative significant correlation was found between symptom severity and stereopsis. 
In other words, the increase of symptom severity was associated with less (better) 
stereopsis and vice versa. 
2) a negative significant correlation was found between symptom severity and the blur 
point in the distance HNFR. In other words, increased symptom severity was associated 
with a lower (worse) blur point value. It is important to mention that in all the HFR tests a 
blur point is not always reported. In this study, only 8 out of the 33 control participants 
reported a blur point in the HNFR test. Therefore, a value of zero was given if the 
participant did not report blur point. This might have caused the negative significant 
correlation in this test. 
3) a negative significant correlation was found between distance VNFR and symptom 
severity on both the break and recovery points. In other words, the increase of symptom 
severity was associated with reduced (poorer) VNFR results. Generally, vertical negative 
fusional reserve values are lower in magnitude than the horizontal negative fusional 
reserve values99, which might have caused the negative significant correlation. Yet, it is 
also possible that the VNFR results were affected by symptom severity in the control 
group. 
The aforementioned significant correlations do not provide enough evidence to suggest that 
overall visual function performance is affected by the severity of symptoms in the control 
participants. This is supported by the fact that no significant correlations were found between 
most of the visual function tests and symptom severity. In addition, it is clear from the scatter 
plot of symptom severity (Figure 3-1) that only few participants in the control group reported 
high symptom severity, which may have also affected the correlation results. Based on these 
results, it can be concluded that the visual function performance does not appear to have been 
affected by symptom severity in controls.  
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5.3.2 Correlation of symptom severity and visual function in the PCS group 
For the PCS group, no significant correlations were found between symptom severity and 
performance on most of the visual function tests. Significant correlations were found for the 
following tests only:  
1) a negative significant correlation was found between the constant and variable errors of 
the CAT test for the 35mph speed only. This indicated that PCS participants with more 
symptom severity tended to have late responses to the stimulus at this particular speed. In 
a similar fashion, PCS participants had more variable responses at the same speed. This 
might indicate a fatigue effect since it occurred towards the end of the test. Yet, this 
observation did not occur in the following and final speed, 40mph. 
2) a positive significant correlation was found between the absolute error of the CAT test 
for the 10mph speed only, which meant that PCS individuals with more severe symptoms 
had higher absolute error values, or were less accurate, when responding to this particular 
stimulus. 
Overall, the visual function test performances that correlated with symptom severity were 
different between the two groups. This might be due to the discrepancy in the number of 
participants between the two groups. Also, this might indicate functional differences between the 
groups despite the presence of symptoms in both of them. It is important to remember that most 
of the PCS symptoms reported were not specifically related to vision, which may explain lack of 
correlation between symptom severity and visual function. 
5.4 Other observations: symptoms and examination length 
As mentioned earlier, there are two school of thoughts about defining PCS. Some specialists 
believe that PCS is directly related to underlying pathophysiological changes in the brain caused 
by the sustained concussion, while others believe that PCS reflects the psychological and 
emotional status of the concussed individual.3,17 It has been proposed that if the PCS symptoms 
get triggered or exacerbated by performing a certain task that requires cognitive and/or physical 
efforts and go away with minimal rest, then, the PCS symptoms would be more likely to reflect 
pathophysiological changes in the brain.3 
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The PCS participants were recruited based on specific inclusion criteria that were chosen to try 
and ensure that the PCS group was homogenous in their PCS condition to some extent. 
However, by looking at the breaks needed and tests causing symptom exacerbations (Table 4-
27), only two participants out of ten did not require breaks nor experience symptom 
exacerbation with the tests. The question then becomes if the PCS group is homogenous, why 
did these two PCS participants not experience worsening of symptoms like the rest of the 
group? Other factors such as adjunct therapies, medications, or time since injury, might have an 
impacted individual’s performances and are harder to account for in a population of PCS 
individuals because there are so many variables that need to be considered. Therefore, for the 
time being at least, it is very important to consider PCS individuals as single cases, especially in 
studies such as this one with a smaller PCS sample.  
Based on the notion that PCS symptoms could be exacerbated by exerting effort, the eight PCS 
participants who experienced symptoms exacerbation and required breaks during the visual 
function assessments are good candidates to support the argument that PCS reflects 
pathophysiological changes in the brain. Particularly because taking rests between tests that 
exacerbated their symptoms helped them recover and continue through the rest of the study 
visit. The breaks participants needed varied in length and also significantly increased the length 
of their study visits. These breaks may have been a better indicator of symptom severity than 
the individual visual function performance measures, especially if the break and exam durations 
had been documented more completely. In future studies it will be important to learn from this 
observation so that visual functions in PCS are not be studied as the test result only. Rather the 
test result, time required to complete the task, and the symptom change associated with the 
task should all be considered.  
The interesting questions that arise from this subjective observation that could be examined in 
future studies include, why did only a few tests exacerbate symptoms out of the wide array of 
visual function tests conducted in this study? Additionally, would the symptom severity or 
number of symptoms change prior to and after conducting these specific tests?  Also, is the 




 - Conclusion 
6.1 Conclusion 
In summary, this study has applied a feasible and a comprehensive visual function testing 
protocol that could be applied in future research and clinical practice.  
The visual function comparison between the two groups demonstrated that some eye 
movement tests (i.e. Broad H) and the King-Devick test have the potential to detect lingering 
deficits in the PCS population. Conversely, PCS individuals still possess what appear to be 
normal to excellent visual functions (i.e. visual-motor reaction time) that might not have been 
affected by the PCS condition. There is a caveat to this conclusion though, which is that high-
level PCS athletes appear to have normal to excellent visual functions when compared to 
recreational and non-athlete controls. In future research, it will be important to compare high-
level PCS athletes with high-level athlete controls to see if the groups’ performance on the 
visual function tests are still comparable. 
Despite meeting strict inclusion criteria, it appears that the PCS population is not homogenous 
and that individuals with PCS need to be considered as single cases in addition to being 
considered as a population. The detailed health history used in the PCS group specifically 
helped with linking some of the PCS details with the abnormal results on visual functions and 
should be collected in future studies as well. Using statistical analysis techniques such as 
multivariate regression may also help account for the wide variability in this population, however 
larger population samples would make this type of analysis more meaningful.  
Moreover, symptom severity on the testing day does not appear to be a predictive variable of 
visual function performance in either the PCS or control individuals. On the other hand, specific 
visual function tests appear to provoke symptoms in the PCS individuals, which affects the time 
required to complete the visual function task. Accounting for symptom changes following tests, 
the need for and duration of breaks between tests, and the overall test and visit durations may 
provide important insight into the relationship between symptom severity and overall visual 




The window for recruiting participants was open for about 9 months. Initially, the intention was to 
collect PCS participants first, then, match them with control participants with the same age, 
gender, and sports activity level for a well-controlled study. However, this could not be achieved. 
In the first 4 months of the recruitment process, only one PCS participant took part in the study 
despite concentrated recruitment efforts that included advertising the study in concussion 
management centres, the University of Waterloo and Wilfrid-Laurier University accessibility 
centres, physiotherapy clinics, and with PCS support groups. Due to the shortage of PCS 
participants recruited, recruitment of control participants was started while taking in any 
prospective PCS participants who came along. Eventually, 10 PCS participants completed this 
study. The number of the PCS group participants was almost one third of the control group 
participants, and resulted in a lack of power in the PCS group that may have affected the ability 
to find differences between the two groups. Another likely reason that differences were not 
found between the two groups was the high amount of variability found within the PCS group 
itself. However, the study still applied a comprehensive and feasible visual function test protocol 
that could be applied on larger group in future research or even to in Optometry clinics to 
assess PCS patients. 
Although the control and the PCS group ended up being fairly well matched with regards to age 
and gender, there was a difference in terms of the sport activity background between the two 
groups that might have affected the study outcomes. The vision in sports literature recommends 
using well-controlled and sport matched study samples, because differences in visual 
performance between different sports and activity levels are present.95,98,100–103 Unfortunately, 
sport and activity level matching created a recruitment challenge that could not be overcome in 
this particular study. 
Another important participant-related limitation of this study was that most of the study 
participants were UW and WLU students. The majority of these students were able to join the 
study between the ends of April and May - right after the final exam period. This time period 
involves tremendous studying efforts, which are visually demanding and may have resulted in 
exhaustion of visual function. The timing of the study visits might also have had an effect on the 
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study outcome, particularly in the control group, and might explain some of the symptoms of the 
control participants as well as some of the unusual behaviours of some of the outliers in the 
control group.  
6.3 Future work 
To continue this study, the PCS participants will be studied as separate cases as was 
recommended earlier. Studying PCS participants as individual cases will allow for accounting for 
different variables such as effect of medications, number of concussions, and time since injury, 
etc. Additionally, statistical analysis will be conducted on selected tests that were repeated three 
times to look for fatigue and/or learning effects over the test trials in both groups. 
Furthermore, this study included the development of an objective VOMS test (Table 2-1) using a 
force plate to measure balance and an eye tracker to measure gaze control. While control and 
PCS data has been collected with this test, the data still needs to be analysed. Examining the 
preliminary results of this objective VOMS test will help to increase our understanding of the 
relationship between balance and eye movement in both groups. 
In future studies it would be good to explore the change in symptoms prior to, during, and after 
testing for the specific visual function tests that provoked symptoms in PCS individuals, and to 
determine if the change in symptoms would affect the test result if the test was repeated. It 
would also be good to examine how long each specific visual function test took to complete for 
each individual. It may be possible that test time (including time needed for breaks) may be a 
better indicator of PCS recovery than simply visual function tests alone. 
Finally, eye movements appear to be a sensitive measure of the visual dysfunction in PCS and 
they may help researchers to detect potential lingering brain deficits associated with PCS. 
Therefore, eye movements should be assessed in an objective and accurate way in all future 
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Headache 0 1 2 3 4 5 6 
“Pressure in head” 0 1 2 3 4 5 6 
Neck pain 0 1 2 3 4 5 6 
Nausea/vomiting 0 1 2 3 4 5 6 
Dizziness 0 1 2 3 4 5 6 
Blurred vision 0 1 2 3 4 5 6 
Balance problems 0 1 2 3 4 5 6 
Sensitivity to light 0 1 2 3 4 5 6 
Sensitivity to noise 0 1 2 3 4 5 6 
Feeling slowed down 0 1 2 3 4 5 6 
“Don’t feel right” 0 1 2 3 4 5 6 
Hard to concentrate 0 1 2 3 4 5 6 
Feeling “in a fog” 0 1 2 3 4 5 6 
Trouble remembering 0 1 2 3 4 5 6 
Fatigue/low energy 0 1 2 3 4 5 6 
Confusion 0 1 2 3 4 5 6 
Drowsiness 0 1 2 3 4 5 6 
Trouble falling asleep 0 1 2 3 4 5 6 
More emotional 0 1 2 3 4 5 6 
Irritability 0 1 2 3 4 5 6 
Sadness 0 1 2 3 4 5 6 




Health History Questionnaire 
 
Participant ID: M/F Date: 




1. At what age did you begin playing 
organized sport? 
9. In the past 6 months, after being hit in the 
head in sports, have you experienced any of 
the following symptoms: 
2. How many years have you played your 
sport?    
 







getting ‘bell rung’ 
ringing in the ears 
  yes 
If yes, what kind? 
stock 
  no 
 
boil & bite 
  blurry vision 
other: 
  poor memory 
  custom, front teeth   custom, all 10. In regards to how you feel NOW, please 
rate the following: 
4. Have you suffered from neck pain within 
the past 6 months?   yes   no 
 
5. Have you suffered a concussion? 
None     Mild Severe 
  yes 
 
6. If yes to #5, 
    _no   not sure 
a) How many times total?    
b) How many times while playing sport in the 
past 6 months?    
c) Date of last concussion?    
d) How long did the symptoms last (for last 
concussion)? 
  1-3 days   4-7 days   8-10 days 
  11-14 days   more than 2 weeks 
e) After the last concussion, how long did you 
refrain from physical activity? 
  4-7 days   8-10 days    11-14 days 
  15-21 days   more than 3 weeks 
 
7. Have you ever been knocked unconscious? 
  yes 
 
8. If yes to #7, 
  no 
a) How many times in the past 6 months?    
b) What is the longest duration you’ve been  
 
11. Do the above symptoms get worse with 
knocked unconscious?    
physical activity?   yes   no 
 
12. Do the above symptoms get worse with 
mental activity?   yes   no 
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CONCUSSION SAFETY PROGRAM INJURY REPORT 
 
 
Participant ID:     Birthdate:   /  /     Sex: (M)  (F) 
 
Sport:    _ Date of Injury:    
INJURY CONDITIONS 
□ Practice □ Warm-up □ Game □ Other:    
CAUSE OF INJURY (check box and circle object) 
□ Hit by object (puck, stick, ball) □ Collision with object (boards, net) □ Fall 
□ Collision with opponent □ Fight □ Other ___   
DESCRIBE INJURY (check all that apply) 
□ Concussion □ Fracture □ Joint/ligament □ Muscle/tendon 
□ Contusion □ Laceration □ None □ Other ___   
LOSS OF CONSCIOUSNESS 
□ None □ 1-20 seconds □ 21-59 seconds □1-2 minutes 
□ 3-5 minutes □ > 5 minutes 
CONFUSION/DISORIENTATION 
□ None □ 1-59 seconds □ 1-2 minutes □ 2-3 minutes 
□ 3-5 minutes □ > 5 minutes 
AMNESIA 
□ None □ 1-10 seconds □ 11-59 seconds □ 1-5 minutes 
□ 6-15 minutes □ > 15 minutes 
RETURNED TO ACTIVITY  
□ after 0-15 min □ after 16-30 min □ after 30-60 min □ did not return 
□ taken to hospital 
REASON FOR RETURN 
□ Stayed on for rest of shift □ Waited for whistle/stoppage of play □ Did not report symptoms 
SYMPTOMS At The Time of The Injury (check all that apply) 
□ Fatigue □ Headache □ Dizziness □ Balance problems □ Visual changes 
□ Nausea □ Vomiting □ Personality change □ Numbness/Tingling 
SIDE OF IMPACT 
□ Left □ Right 
POINT OF IMPACT 
□ Frontal □ Parietal □ Temporal □ Occipital 
□ Nasal □ Jaw □ Body 
MOUTH GUARD 
□ Yes □ No 
HELMET WORN 
□ Yes □ No/Not required for sport □ Came off due to impact 
DESCRIBE INJURY 
 
AUTHOR _____________________________________ DATE _____________________________________ 
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Participant:_____________________ M /F   Date:________________________________  




1- Do you wear any type of vision correction (i.e. glasses, contact lenses)? if yes please specify. 
2- Have you been diagnosed with any eye problem? (If your answer is NO please go to question 6) 
3- Could you specify what was the problem? 
*This question is only for individuals who have had concussion. 
4- Could you specify if this problem was prior or after the concussion? 
5- Have you ever received a vision therapy (orthoptic treatment)? 
6- Do you have a family history of eye problem? if yes please specify. 




Appendix B - Does athletic background affect visual function? 
B.1 Introduction 
As discussed previously (see Chapter 5 - Discussion), the control and PCS groups performed 
almost equally on all of the visual function measures tested. The differences in performance on 
the visual function test could not be fully explained by the symptoms of either group. One 
possibility is that athletic background had some impact on visual performance as previous 
research has demonstrated that in some aspects of visual function, athletes perform better than 
non-athletes 93,95,104–109 (Table B.1).  
All of the PCS participants in this study were athletes, whereas only about half of the control 
group was athletes (see Chapter 3, Table 3-1). Perhaps the reason for the lack of obvious 
difference in visual function between the two groups was because the athletic background of the 
PCS group made up for their visual function deficits compared to controls. To investigate 
whether this might be a factor impacting the results of this thesis, the decision was made to 
compare performance on the visual function measures between the non-athlete control 
participants and the athlete control participants. If the athlete controls performed significantly 
better on the visual function tests than the non-athlete controls, than it might be more 
appropriate to compare the PCS athletes with the control athletes only in future studies.   
In order to have a better understanding about the relationship between athletic background and 
performance on the visual function measures, participants within the control group were split 
into two subgroups: 1) non-athletes (n=16) 2) athletes (n=17). It is important to mention that this 
comparison was not intended when this study was designed. Therefore, athletic participants 
were not recruited based on a specific criterion, and they were simply assigned to one of the 
groups based on whether the participant practice sport or not. Although this analysis was not 
intended when this study was designed, the athletic background remain an interesting variable 
to look at. Hence, this part was added as an appendix rather than embedded within the thesis. 
A Mann-Whitney U-test was performed to look at the difference in the visual functions between 




Table B-1: Literature review of visual functions in athlete versus non-athlete populations 
Study Study Sample Visual Function Methods Conclusion Significance 













Push-up technique with RAF 
rule 
Athletes significantly better 
OD - p=0.02 
OS - p=0.05 
OU - p=0.03 
Accommodation 
Facility 
Using ±2.00 D lens flipper No significant difference 
OD - p=0.38 
OS - p=0.32 
Ocular 
misalignment 
Horizontal ocular misalignment 
measured at distance with 
prism bar and Howell card as a 
target 
No significant difference p=0.44 
Near point of 
convergence 






Using 12 base-out/3 base-in 
prism flipper 








Positive HFR - recovery point No significant difference p=0.44 

















Using MEM technique No significant difference p=0.16 
Near point of 
convergence 
a fixation stick 
with 20/30 single 
letter target 
Break point 


















Positive HFR - break point Athletes were significantly 
better 
p=0.01 
Positive HFR - recovery point p=0.01 
Negative HFR - break point 
No significant difference 
p=0.76 
Negative HFR - recovery point p=0.81 
Near horizontal 
fusional reserve 
Positive HFR - break point Athletes had marginally 
significant higher values 
p=0.06 
Positive HFR - recovery point p=0.06 
Negative HFR - break point 
No significant difference 
p=0.67 
Negative HFR - recovery point p=0.93 
Accommodation 
facility 
By shifting vision from distance 
(5 m) to near (40 m) using Hart 
charts as targets 
No significant difference p=0.12 
Stereo acuity 
Distance stereo acuity 
No significant difference 
p=0.81 
Near stereo acuity p=0.13 
Reaction time 
Eye-hand coordination was 
measured using Wayne 
saccadic fixator 
No significant difference p=0.02 










Eye movements were recorded 
using 120 Hz eye tracker 











(21.6 ± 1.5) 
Dynamic visual 
acuity 
Using Landolt C as a target 
with the following gap sizes 8’, 
14’, 28’, and 42’. The target 
speed range was 300 - 
200/sec. 
Athletes were better than 
non-athletes only in 

















Head moved in horizontal 
metronome of 150°/sec. for OD 
and OS 
No significant difference 
OD - p=0.74 
 
OS - p=0.52 









age 13.8 years 
Static near stereo 
acuity 
Randot stereo-acuity test 
(circles) 










Pitching ball machine at the 
following speeds 35, 40, 45, 
and 50 
No significant difference p>0.05 
Ando, et al. 
(2001)93 
Soccer players 
(n=6); age  
(21.5 ± 1.4) 
 
Non-athletes 
(n=6); age  




Stimulus presented on a 
computer screen with different 
stimulus sizes and different 
distances. Response given 
using the computer space key. 
No significant difference 
found between the groups. 
Therefore, groups were 
combined together to look at 
the difference between size 














age (22 ± 1.9) 
Visual motor 
response time 
40 random lights on the Sport 
Vision Trainer board 
No significant difference 
between athletes and non-





Overall, there was no significant difference between the athlete and non-athlete groups (Table 
B.2) on most of the visual functions except for the following: 
4) Accommodation accuracy: OS (p=0.04). The non-athletes appear to have better 
accommodation accuracy (less lag of accommodation at near) than the control group. 
5) Distance horizontal negative fusional reserve: Break point (p=0.02) and recovery point 
(p=0.03). The non-athlete group appear to have better distance HNFR in break and 
recovery points than the athlete group. 
Additionally, there was marginally significant difference between the groups in the distance 
vertical positive fusional reserve (recovery point p=0.05). The non-athlete group appear to have 




Table B-2: Results of athlete and non-athlete groups 
 Athlete Non-athlete p-value 
 Mean ± SD Median Mean ± SD Median  
Number of symptoms 
Visit 1 4.6 ± 6.0 2.5 2.4 ± 3.3 1.0 0.47 
Visit 2 3.6 ± 4.9 2.0 2.0 ± 3.1 0.0 0.20 
Symptom severity 
Visit 1 4.4 ± 7.8 1.0 9.4 ± 13.2 4.0 0.43 
Visit 2 3.3 ± 5.8 0.0 5.4 ± 7.8 2.5 0.22 
Objective refraction 
OD -2.9 ± 3.7 -1.1 -2.4 ± 3.4 -1.1 0.44 
OS -2.9 ± 3.7 -0.6 -2.3 ± 3.2 -0.7 0.48 
Distance visual acuity 
OD -0.04 ± 0.13 -0.09 -0.05 ± 0.01 -0.08 0.98 
OS -0.04 ± 0.11 -0.08 -0.05 ± 0.13 -0.08 0.74 
OU -0.10 ± 0.10 -0.10 -0.12 ± 0.10 -0.16 0.69 
Near visual acuity 
OD 0.41 ± 0.03 0.40 0.43 ± 0.05 0.40 0.40 
OS 0.40 ± 0.00 0.40 0.41 ± 0.03 0.40 >0.99 
OU 0.40 ± 0.00 0.40 0.40 ± 0.00 0.40 >0.99 
Dynamic visual acuity 
Horizontal 0.06 ± 0.1 0.00 0.1 ± 0.1 0.00 0.58 
Jitter -0.13 ± 0.1 -0.10 0.12 ± 0.1 -0.20 0.93 
Random 0.11 ± 0.2 0.10 0.1 ± 0.1 0.15 0.70 
Contrast sensitivity 
OU 1.99 ± 0.06 2.00 2.01 ± 0.06 2.00 0.59 
Distance cover test 
Primary -1.2  2.7 0.0 0.1  1.4 0.0 0.11 
Left -1.1  2.2 0.0 -0.1  1.1 0.0 0.19 
Right -1.1  2.2 0.0 -0.1  1.1 0.0 0.19 
Near cover test 
Primary -1.9  3.9 -1.50 -0.3  2.3 0.0 0.20 
Left -2.2  3.7 -1.50 -0.4  2.2 0.0 0.14 
Right -2.2  3.7 -1.50 -0.4  2.2 0.0 0.14 
Stereopsis 
 25.4 ± 12.5 20.0 34.9 ± 19.2 26.7 0.06 
Amplitude of accommodation 
OD 0.9 ± 1.8 0.8 0.7 ± 2.0 0.7 0.82 
OS 1.3 ± 1.7 0.8 1.1 ± 2.2 0.8 0.42 
Absolute 
difference 
0.9 ± 0.9 0.8 0.6 ± 0.7 0.7 0.38 
Accommodation accuracy 
OD 0.45 ± 0.65 0.25 0.80 ± 0.44 0.75 0.08 
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OS 0.39 ± 0.61 0.50 0.72 ± 0.34 0.75 0.04* 
Absolute 
difference 
0.19 ± 0.21 0.25 0.10 ± 0.13 0.00 0.30 
Cyclopean eye 
 n=6 n=11  
 80.4  6.3 81.9 82.4  4.7 81.7 0.94 
Relative accommodation 
 n=4 n=6  
NRA 2.90  0.60 3.00 2.40  0.70 2.50 0.33 
PRA -4.40  2.40 -3.25 -2.50  0.60 -2.75 0.07 
Accommodative facility 
OD 10.7 ± 6.3 10.5 9.1 ± 6.5 9.0 0.49 
OS 12.1 ± 6.9 11.3 10.0 ± 6.8 11.0 0.47 
Absolute 
difference 
2.9 ± 3.0 1.5 1.9 ± 2.0 2.0 0.33 
Near point of convergence 
Break 5.7 ± 2.8 5.2 5.0 ± 3.1 6.0 0.57 
Recovery 6.9 ± 3.2 7.2 6.0 ± 3.5 7.0 0.36 
Difference 1.2 ± 0.7 1.2 1.1 ± 0.9 1.0 0.47 
Distance horizontal positive fusional reserve 
Blur 7.2 ± 7.4 7.0 7.2 ± 6.8 8.0 0.98 
Double 19.0 ± 7.0 19 21.0 ± 7.7 25 0.49 
Recovery 1.9 ± 3.3 16 1.3 ± 2.7 14 0.54 
Distance horizontal negative fusional reserve 
Blur 1.9 ± 3.3 0.0 1.3 ± 2.7 0.0 0.54 
Double 8.8 ± 2.3 8.0 6.6 ± 2.9 6.0 0.02* 
Recovery 6.3 ± 2.3 6.0 4.4 ± 2.7 4.0 0.03* 
Distance vertical positive fusional reserve 
Double 3.6 ± 1.4 3.0 2.9 ± 0.9 3.0 0.07 
Recovery 2.2 ± 1.1 2.0 0.2 ± 0.7 1.0 0.05 
Distance vertical negative fusional reserve 
Double 3 ± 1.6 3.0 2.3 ± 0.8 2.0 0.18 
Recovery 1.7 ± 1.0 1.5 1.3 ± 0.8 1.0 0.33 
Near horizontal positive fusional reserve 
Blur 3.7 ± 7.8 0.0 4 ± 5.5 0.0 0.37 
Double 17.6 ± 8.8 18.0 16.5 ± 9.6 16.0 0.69 
Recovery 13.5 ± 7.3 15.0 12.2 ± 7.2 14.0 0.71 
Near horizontal negative fusional reserve 
Blur 5.4 ± 6.9 0.0 1.5 ± 6.9 0.0 0.16 
Double 13.3 ± 5.0 12.0 11.3 ± 3.6 12.0 0.33 
Recovery 10.6 ± 4.5 10.0 9.2 ± 3.5 10.0 0.51 
Near vertical positive fusional reserve 
Double 4.0 ± 1.3 4.0 3.2 ± 0.7 3.0 0.07 
Recovery 2.8 ± 1.2 2.0 2.1 ± 0.7 2.0 0.16 
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Near vertical negative fusional reserve 
Double 3.3 ± 2.0 3.0 2.9 ± 0.7 3.0 0.13 
Recovery 2.3 ± 1.1 2.0 1.9 ± 0.7 2.0 0.21 
Vergence facility 
 15.1 ± 5.3 16.0 16.4 ± 4.5 18.0 0.61 
King-Devick 
Time 49.18 ± 10.53 48.35 47.08 ± 16.34 39.90 0.22 
Errors 0.63 ± 2.25 0.00 0.00 ± 0.00 0.00 0.23 
Visual-motor reaction time 
Central 510.7 ± 118.1 502.7 507.6 ± 116.1 489.1 0.91 
Peripheral 995.5 ± 268.7 908.9 850.8 ± 159.7 785.2 0.06 
Constant error 
Speed Mean ± SD Median Mean ± SD Median p-value 
5 -25.3 ± 38.4 -9.7 -23.1 ± 24.8 -26.6 0.84 
10 -5.2 ± 20.3 -2.4 -21.5 ± 29.8 -23.2 0.11 
15 -10.0 ± 24.9 -14.1 -19.2 ± 27.5 -23.4 0.34 
20 -8.3 ± 19.6 -10.6 -9.8 ± 17.1 -9.8 0.79 
25 -2.7 ± 19.5 0.8 0 ± 24.3 -1.6 0.82 
30 16.5 ± 23.9 16.3 7.5 ± 23.0 5.2 0.32 
35 11.3 ± 19.8 9.8 11.9 ± 22.7 11.8 0.84 
40 19.7 ± 19.1 13.9 18.4 ± 16.1 15.6 0.74 
Average error 
5 46.8  28.2 36.6 47.8  18.0 37.8 0.44 
10 30.6  15.4 30.0 38.5  21.0 31.6 0.23 
15 46.5  20.0 46.3 47.13  28.3 38.6 0.53 
20 50.8  20.4 50.3 43.6  18.0 40.8 0.26 
25 41.4  17.2 37.5 40.3  16.5 39.8 0.99 
30 39.8  17.5 33.8 40.1  14.4 41.0 0.98 
35 37.3  23.1 35.0 29.1  11.8 27.8 0.51 
40 29.1  18.3 24.8 35.3  19.0 30.8 0.26 
Variable error 
5 40.0  18.2 36.6 44.5  16.8 40.2 0.27 
10 30.2  15.6 27.7 35.3  18.2 29.9 0.45 
15 51.2  26.4 47.0 48.5  37.6 37.1 0.39 
20 57.1  28.4 53.4 47.6  22.6 41.8 0.31 
25 47.3  19.8 42.7 44.3  17.7 49.7 0.99 
30 39.3  15.4 38.3 41.1  15.2 38.0 0.85 
35 41.3  24.5 36.4 29.0  11.0 26.6 0.23 
40 27.9  16.3 23.7 36.2  23.2 32.2 0.20 





As it is clear from the results, the athlete group’s performance on the visual function tests was 
not significantly better than the non-athlete group on any of the tests. On the other hand, the 
non-athlete group visual function performance was better in the accommodation accuracy (OS) 
and distance horizontal negative fusional reserve (double and recovery points) tests. Although 
this finding is not consistent with the previous literature (Table B-1), it indicates that the athletic 
background was not the reason behind the lack of difference between the control and PCS 
analysis in this study. 
One possible explanation for the lack of difference between the athlete and non-athlete control 
groups in this study is that most of the athlete group participants (15 out of 17) were involved in 
recreational sports (Table 3-1). In other words, their sport practice may have been irregular and 
was not at a high enough level to allow for the development of superior visual functions (unlike 
the more elite and competitive athletes studied in the previous literature).  
